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Given evidence that the pain of migraine originates in the peripheral dural afferents, and that 
sterile inflammation contributes to the activation and sensitization of dural afferents, the question 
addressed in this dissertation was, how is inflammation in the dura initiated, which could then 
lead to the start of a migraine attack?  Immune cells are one well-known primary source of 
inflammatory mediators and likely, at least in part, responsible for sterile dural inflammation.  
Therefore, changes in dural immune cells were characterized in association with three, key 
clinical features of migraine—that migraine is more common in women than in men, stress is the 
most common trigger for a migraine attack, and sympathetic dysregulation is observed in 
migraineurs.  Dural immune cells were obtained for flow cytometry and fluorescence activated 
cell sorting from male or female, naïve or stressed, intact or with surgical denervation of 
sympathetic post-ganglionic neurons, adult Sprague Dawley rats.  The total proportion of 
immune cells in the dura was identified for the first time, as well as the presence of lymphoid 
derived dural immune cells, even in naïve animals.  Immune cell subtypes (macrophages in 
males, and T-cells in females) increased with a delay after stress, suggesting for the first time a 
possible role for T-cells in migraine.  Furthermore, pro- (TNFα and IL-6) and anti- (IL-10 and 
POMC) inflammatory mediator mRNA expression was up- and down-regulated, respectively, in 
myeloid and lymphoid dural immune cells with a delay after stress, particularly in females, 
suggesting that a shift in the balance of pro- and anti-inflammatory mediators may also 
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contribute to the initiation of a migraine attack.  This dissertation expands the current view of the 
dura, revealing it to be a much more immune rich and complex tissue than previously 
appreciated.  Most importantly, this work underscores the possibility that it may not only be 




TABLE OF CONTENTS 
PREFACE ................................................................................................................................. XIII 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 NEUROBIOLOGY OF MIGRAINE ................................................................. 1 
1.2 SEX DIFFERENCE AND GONADAL HORMONE REGULATION OF 
MIGRAINE ........................................................................................................................... 8 
1.3 STRESS AS A MIGRAINE TRIGGER .......................................................... 10 
1.4 EVIDENCE OF A SPGN CONTRIBUTION TO MIGRAINE PAIN ......... 14 
1.5 IMMUNE SYSTEM CONTRIBUTION TO MIGRAINE PAIN .................. 17 
2.0 SEX-, STRESS-, AND SYMPATHETIC POST-GANGLIONIC-DEPENDENT 
CHANGES IN THE IDENTITY AND PROPORTIONS OF IMMUNE CELLS IN THE 
DURA 23 
2.1 INTRODUCTION ............................................................................................. 24 
2.2 METHODS ......................................................................................................... 26 
2.2.1 Animals ........................................................................................................... 26 
2.2.2 Chronic variable stress (CVS) ...................................................................... 27 
2.2.3 Bilateral superior cervical ganglion sympathectomy (SPGNx) ................. 28 
2.2.4 Isolation of dural cells ................................................................................... 29 
2.2.5 Flow cytometry and fluorescence activated cell sorting (FACS) .............. 30 
 vii 
2.2.6 Cell histology .................................................................................................. 34 
2.2.7 Immunohistochemistry ................................................................................. 34 
2.2.8 Data analysis .................................................................................................. 35 
2.3 RESULTS ........................................................................................................... 37 
2.3.1 Immune cell types present in the dura......................................................... 38 
2.3.2 Sex, stress, and sympathetic innervation influence dural immune cell 
proportions ................................................................................................................. 42 
2.3.2.1 Immune cells in the dura .................................................................... 42 
2.3.2.2 Myeloid derived dural immune cell subtypes ................................... 44 
2.3.2.3 Lymphoid derived dural immune cell subtypes ............................... 47 
2.3.2.4 “Unidentified” dural immune cell subtypes ..................................... 48 
2.4 DISCUSSION ..................................................................................................... 53 
3.0 SEX-, STRESS-, AND SYMPATHETIC POST-GANGLIONIC NEURON-
DEPENDENT CHANGES IN THE EXPRESSION OF PRO- AND ANTI-
INFLAMMATORY MEDIATORS IN RAT DURAL IMMUNE CELLS ............................ 58 
3.1 INTRODUCTION ............................................................................................. 59 
3.2 METHODS ......................................................................................................... 61 
3.2.1 Animals ........................................................................................................... 61 
3.2.2 Chronic variable stress (CVS) ...................................................................... 62 
3.2.3 Bilateral superior cervical ganglion sympathectomy (SPGNx) ................. 63 
3.2.4 Isolation of dural cells ................................................................................... 63 
3.2.5 Fluorescence activated cell sorting (FACS) ................................................. 64 
3.2.6 Real time polymerase chain reaction (qPCR) ............................................. 67 
 viii 
3.2.7 Data Analysis.................................................................................................. 70 
3.3 RESULTS ........................................................................................................... 71 
3.3.1 Myeloid derived dural immune cells: pro-inflammatory mediators ........ 72 
3.3.2 Myeloid derived dural immune cells: anti-inflammatory mediators ........ 76 
3.3.3 Lymphoid derived dural immune cells: pro-inflammatory mediators ..... 78 
3.3.4 Lymphoid derived dural immune cells: anti-inflammatory mediators .... 82 
3.4 DISCUSSION ..................................................................................................... 84 
4.0 DISCUSSION ............................................................................................................. 88 
4.1 IDENTIFICATION AND CHARACTERIZATION OF IMMUNE CELLS 
IN THE DURA .................................................................................................................... 88 
4.2 STUDYING SEX DIFFERENCES .................................................................. 91 
4.3 USING CHRONIC VARIABLE STRESS AS AN APPROACH TO 
IDENTIFY HOW INFLAMMATION IS INITIATED IN THE DURA ....................... 92 
4.4 EXAMINING THE IMPACT OF SPGN INNERVATION .......................... 94 
4.5 FUTURE DIRECTIONS................................................................................... 96 
4.6 SUMMARY AND CONCLUSIONS ................................................................ 99 
APPENDIX A ............................................................................................................................ 101 
APPENDIX B ............................................................................................................................ 120 
APPENDIX C ............................................................................................................................ 125 
BIBLIOGRAPHY ..................................................................................................................... 131 
 ix 
 LIST OF TABLES 
 
Table 1.  Primer sequences (5’3’) ............................................................................................. 69 
 x 
LIST OF FIGURES 
Figure 1.  Experimental design. .................................................................................................... 32 
Figure 2.  Proportion of immune cell subtypes in the naïve male dura as determined with flow 
cytometry using the gating strategy shown in Figure 1B. ............................................................ 39 
Figure 3.  Distribution of immune cells in the naïve male dura. .................................................. 41 
Figure 4.  Sex-, stress- and SPGN-dependent changes in the percent of CD45+ immune cells in 
the dura (relative to the total number of live cells recovered). ..................................................... 43 
Figure 5.  Sex-, stress- and SPGN-dependent changes in the percent of myeloid derived immune 
cells dissociated from the dura (relative to the total number of live cells from each dura). ......... 46 
Figure 6.  Sex-, stress- and SPGN-dependent changes in the percent of lymphoid derived 
immune cells dissociated from the dura (relative to the total number of live cells from each dura).
....................................................................................................................................................... 51 
Figure 7.  Sex-, stress- and SPGN-dependent changes in the percent of unidentified immune cells 
dissociated from the dura (relative to the total number of live cells from each dura). ................. 52 
Figure 8.  Gating strategy example used for the isolation of myeloid and lymphoid immune cell 
subtypes from the dura. ................................................................................................................. 66 
Figure 9.  Sex-, stress-, and SPGN- dependent changes in pro-inflammatory mediators in dural 
myeloid cells. ................................................................................................................................ 75 
 xi 
Figure 10.  Sex-, stress-, and SPGN- dependent changes in anti-inflammatory mediators in dural 
myeloid cells. ................................................................................................................................ 77 
Figure 11.  Sex-, stress-, and SPGN- dependent changes in pro-inflammatory mediators in dural 
lymphoid cells. .............................................................................................................................. 81 
Figure 12.  Sex-, stress-, and SPGN- dependent changes in anti-inflammatory mediators in dural 
lymphoid cells. .............................................................................................................................. 83 
 
Appendix A Figure 1. ................................................................................................................. 115 
Appendix A Figure 2. ................................................................................................................. 116 
Appendix A Figure 3. ................................................................................................................. 118 
Appendix A Figure 4. ................................................................................................................. 118 
Appendix A Figure 5. ................................................................................................................. 119 
 
Appendix B Figure 1.  Increased TH-LI vasculature-independent fibers in dura of R192Q mutant 
mice. ............................................................................................................................................ 123 
Appendix B Figure 2.  Increased TH-LI innervation in female R192Q mutant mice ear tissue. 124 
 
Appendix C Figure 1.  Stress-induced, sex-dependent changes in dural mast cell degranulation 
are regulated by SPGNs. ............................................................................................................. 127 
Appendix C Figure 2.  No change in density of dural mast cells. .............................................. 128 
Appendix C Figure 3.  Stress-induced, sex-dependent changes in dural plasma extravasation are 
SPGN dependent. ........................................................................................................................ 129 
 xii 
Appendix C Figure 4.  Stress-induced increases in plasma extravasation in the ear is SPGN 




This dissertation is dedicated in memory of Susan Carrie Stitt McIlvried.  As both my mother 
and a migraineur, she taught me strength, passion, value, dedication, and courage—a foundation 
of tools I needed to make it through graduate school.  I would also like to thank the rest of my 
incredibly supportive family, as well as my “statistically significant” other, Andrew Renckly 
(p<0.001 for the endless encouragement).   
Most directly, this work was made possible due to the guidance of my advisor, Dr. 
Michael Gold.  He pushed my development as a scientist, leading by example with an enduring 
curiosity of science that often manifested as “begging of questions”.  I have also greatly 
appreciated the support of the entire Gold Lab through all these years.  In particular, Dr. Andrea 
Harriott started migraine research in Michael’s lab and initially mentored me, and Dr. Nicole 
Scheff single-handedly kept me sane.   
I am grateful to all the committee members for offering advice and valuable feedback 
throughout the process to help keep me moving forward.  Specifically, it has been a privilege to 
have Dr. Jerry Gebhart serve as chair and share his wisdom before retirement.  Additionally, 
most of the work presented in this dissertation was a collaboration with Dr. Lisa Borghesi in the 
Immunology Department.  She offered resources and guidance to help me develop these 
experiments, which I immensely appreciate.   
 xiv 
Last but not least, I would like to thank Patti Argenzio and the Center for Neuroscience at 
the University of Pittsburgh (CNUP) as well as Joanne Hirt and the Pittsburgh Center for Pain 
Research (PCPR) for their continued support of students and pain research. 
 1 
1.0  INTRODUCTION 
1.1 NEUROBIOLOGY OF MIGRAINE 
Migraine is a common, debilitating pain disorder with high impact on both the patient and 
society.  There is a clear sex difference in the manifestation of this disorder which has a 
prevalence of 6-8% in men and 15-25% in women.  The first migraine attack commonly occurs 
at puberty, and frequency of attacks decreases in females after menopause (Goadsby, 2007).  
Consequently, this is a disorder that takes its toll over peak years in productivity.  Migraine is 
ranked as one of the 20 most disabling diseases, according to the World Health Organization 
(Leonardi et al., 2005).  The annual cost to employers is estimated between $12-17 billion, and 
yearly medical costs exceed $1 billion (Silberstein, 2004, Goldberg, 2005, Leonardi et al., 2005, 
Hawkins et al., 2007).  Given that there is no known cure for migraine, and the available 
treatments are only effective in a fraction of patients (Goadsby, 2007), there is a significant need 
for the identification of novel therapeutic approaches for this disorder. 
Criteria established by the International Headache Society in the International 
Classification of Headache Disorders (ICHD) are used to diagnose migraine.  To meet the 
diagnosis of migraine, a patient must present with the occurrence of at least 5 headaches that 
fulfill two sets of criteria.  First, the headaches must have at least two of the following: unilateral 
location, pulsating quality, moderate to severe pain intensity, and/or aggravation by movement.  
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Second, the headaches must be associated with at least one of the following: nausea/vomiting 
and/or photophobia/phonophobia (Lipton et al., 2004).  In 20-30% of migraineurs, attacks are 
preceded by an aura, and diagnosed as “migraine with aura.”  The aura must be fully reversible, 
occur within 60 min of the start of the headache, and meet two additional sets of criteria.  First, it 
must be associated with visual symptoms including positive features (scintillations—flickering) 
and/or negative features (scotoma—loss of vision), sensory symptoms including positive features 
(pins and needles) and/or negative features (numbness), or dysphasia (speech disturbance). 
Second, it must also be associated with development of aura symptoms over ≥5 min and/or each 
symptom lasting between 5 and 60 min (Lipton et al., 2004).  
The most prominent feature of migraine is pain.  Pain traditionally involves activation of 
specialized sensory afferents, colloquially referred to as nociceptors, that are responsive to 
noxious or potentially damaging stimuli.  Nociceptors synapse centrally on the dorsal horn.  
Dorsal horn neurons in turn transmit this information to higher order brain structures to be 
interpreted as “pain.”  For migraine pain, this would involve activation of trigeminal (ophthalmic 
branch) afferents that innervate the meninges and associated blood vessels.  Meningeal afferents 
have central projections to the trigeminocervical complex (TCC), consisting of C1 and C2 dorsal 
horns of the cervical spinal cord and the trigeminal nucleus caudalis (TNC).  Neurons within 
TCC, in turn, project to ventroposteriomedial (VPM) and posterior (Po) thalamic nuclei, in 
addition to several brainstem nuclei as well as the hypothalamus (Pietrobon and Moskowitz, 
2013).  Dura-sensitive VPM neurons project mainly to cortical areas considered part of the pain 
matrix (i.e. somatosensory cortices and insular cortex), and are thought to play a role in the 
perception of the pain.  Dura-sensitive Po neurons project to non-traditional “pain” cortical areas 
(i.e. auditory, visual, retrosplenial, parietal association cortices) and are thought to contribute to 
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other symptoms experienced during an attack such as altered limbic function, memory and 
cognitive performance (Noseda et al., 2011).  Activation of the brainstem and hypothalamic 
nuclei are thought to contribute to various symptoms experienced during an attack, such as loss 
of appetite, nausea, sleepiness, irritability, fluid retention, and autonomic symptoms (Akerman et 
al., 2011).  Additionally, the TCC receives descending projections from the cortex and 
particularly brainstem.  Stimulation of the periaqueductal gray (PAG) or rostral ventral medulla 
(RVM) inhibits TCC responses to dural stimulation (Knight and Goadsby, 2001, Lambert et al., 
2008, Akerman et al., 2011).  The hypothalamus also has also been shown modulate TCC 
responses to dural stimulation (Bartsch et al., 2004, 2005, Charbit et al., 2009).   
 While there is still much to be resolved about this disorder, a topic of ongoing 
debate is the source of the headache pain.  There are essentially two camps on this question, with 
one camp arguing in favor of the sensitization of afferents that innervate the meninges as the 
primary source of the pain, and the other arguing that the pain arises from within the central 
nervous system (CNS).  Some of the most convincing evidence in support of the activation and 
sensitization of meningeal afferents comes from early studies of stimulation of the meninges in 
patients during brain surgery.  Stimulation of the meninges and associated vasculature produced 
a sensation of pain that was qualitatively similar to that associated with a migraine (Ray and 
Wolff, 1940).  Additionally, it has been reported over time that craniotomies and surgical 
disruption of the meninges performed for unrelated medical reasons (i.e., removal of neuromas) 
produced headaches for months in patients (4-84%, depending on the study), and even induced 
chronic headaches in some (Olesen et al., 2009).     
 Additional evidence in support of meningeal afferents as the source of migraine 
pain comes from evidence that migraine is associated with sterile inflammation of the dura.  A 
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critical component of this inflammation is thought to be mediators released that are able to 
activate and sensitize dural afferents.  Clinical data are consistent on the fact that migraine 
attacks are associated with increased levels of many inflammatory mediators in the plasma and 
CSF (Sarchielli et al., 2000, Perini et al., 2005, Waeber and Moskowitz, 2005, Fidan et al., 2006, 
Sarchielli et al., 2006).  Non-steroidal anti-inflammatory drugs (NSAIDS) are also an effective 
acute treatment for migraine (Jakubowski et al., 2005).  Preclinical evidence for the sterile 
inflammation hypothesis comes from the observation that the majority of dural afferents express 
the neuropeptides calcitonin-gene related peptide (CGRP) and substance P (SP) (Uddman et al., 
1989, Messlinger et al., 1993, Shimizu et al., 2007).  I have also shown that 66.0 ±6.0% of 
retrogradely labeled dural afferents express CGRP (McIlvried et al., 2010)(Apppendix).  
Peripheral release of these peptides produces local vasodilation, plasma extravasation, and 
degranulation of mast cells.  These processes further release pro-inflammatory mediators and 
result in a pro-inflammatory feedback loop, known as sterile inflammation (Waeber and 
Moskowitz, 2005, Pietrobon and Moskowitz, 2013).  Studies have also shown that application of 
pro-inflammatory mediators to dural afferents result in an increase in excitability (Strassman et 
al., 1996, Harriott and Gold, 2009).  Evidence that this generic feedback loop may occur in the 
dura was provided by Levy and colleagues (2007) who demonstrated that mast cell degranulation 
in the dura is sufficient to drive dural afferent activity (Levy et al., 2007).  Importantly, events 
associated with migraine, such as cortical spreading depression (CSD), the physiological 
phenomenon thought to underlie aura, are sufficient to drive mast cell degranulation (Karatas et 
al., 2013), and subsequently sensitization of dural afferents (Zhang et al., 2010).  Similarly, 
triggers for migraine such as nitroglycerin (GTN) infusion, which induces a delayed migraine 
attack in migraineurs but not controls (Thomsen et al., 1994), also induced delayed mast cell 
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degranulation and inflammation in the rat dura (Reuter et al., 2001), as well as the sensitization 
and activation of dural afferents (Jones et al., 2001, Lambert et al., 2002).   
CGRP has become a particularly important molecule in migraine because 1) CGRP is 
increased in plasma during attacks (Goadsby et al., 1990, Goadsby and Edvinsson, 1993), 2) 
infusion of CGRP produces a delayed migraine headache in migraineurs (Lassen et al., 2002), 
and 3) CGRP receptor antibodies have recently been identified as an effective treatment for 
migraine (Bigal et al., 2015).  While the increase in CGRP levels observed during attacks could 
be due to central or peripheral sources, and CGRP receptors are present both centrally and 
peripherally (Lennerz et al., 2008), the successful use of CGRP to induce attacks, as well as 
antibodies to treat migraine, points to a peripheral site of action for at least the initiation of 
migraine pain, as neither peptide nor antibody should readily cross the blood brain barrier 
(Edvinsson et al., 2007, Asghar et al., 2012).  Similarly, administration of other pro-
inflammatory molecules that poorly cross the blood brain barrier such as histamine and PACAP 
are also able to induce migraine attacks (Lassen et al., 1995, Schytz et al., 2009).   
 Another line of evidence in support of the peripheral hypothesis comes from the 
changes observed following application of inflammatory soup to the dura.  This is now widely 
used as a pre-clinical model of migraine because it results in periorbital mechanical allodynia 
(Edelmayer et al., 2009).  Allodynia is a term used to describe the perception of pain in response 
to normally innocuous stimuli.  Dynamic mechanical allodynia, which is pain associated with 
light brushing of the skin, is commonly associated with painful peripheral neuropathies such as 
diabetic or post-herpetic neuropathy.  Because the stimulus intensities capable of evoking 
mechanical allodynia are well below those needed to activate even sensitized nociceptive 
afferents, this phenomena is thought to reflect changes in a neural circuit enabling low threshold 
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afferent input to the dorsal horn to gain access to nociceptive circuits in the presence of injury 
and/or following a burst of activity in nociceptive afferents (LaMotte et al., 1991).  Mechanical 
allodynia is present in 63% (Lipton et al., 2008) to 79% (Burstein et al., 2000) of migraineurs, 
approximately an hour after the onset of pain.  As is the case for neuropathic pain, the allodynia 
associated with migraine is thought to result from sensitization of second order TCC neurons that 
also receive input from facial cutaneous afferents (Dodick and Silberstein, 2006).  Thus, the 
presence of mechanical allodynia following application of inflammatory mediators to the dura 
enables pre-clinical investigators to infer the presence of a headache. 
Despite this evidence, there are still no direct data of a pathophysiology of the dura or an 
increase in meningeal afferent activity during a migraine.  Many investigators cite this reason to 
support the hypothesis of a central origin of headache pain.  Several different observations 
provide additional evidence in support of a central origin of the migraine attack.  First, 
premonitory symptoms such as tiredness, yawning, mood change, and gastrointestinal symptoms 
have been described in 32.9% of patients for 9.42 hours preceding an attack (Kelman, 2004), 
suggesting activation of CNS pathways before an attack.  Second, CSD is a propagating wave of 
excitation followed by a wave of depression that moves across the cortex at 3-5mm/min and has 
been correlated with the aura preceding attacks in 20-30% of migraineurs (Pietrobon and 
Striessnig, 2003).  Again, that this is, by definition a CNS event that precedes an attack lends 
support to a central origin of pain.  Lastly, the most compelling model to account for a central 
origin of migraine pain involves a “brainstem generator,” (i.e., in the PAG and/or RVM), that 
drives sensitization and/or activation of TCC neurons independent of aberrant peripheral input 
(Akerman et al., 2011).  It has long been appreciated that the regulation of pain by the RVM is 
bi-directional, where descending facilitation results in an increase in the response to nociceptive 
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input at the level of the trigeminal and spinal dorsal horn (Gebhart, 2004).  The possibility that 
such a process may be sufficient to account for migraine was supported by data from Lambert 
and colleagues who showed that a lidocaine block of the trigeminal ganglion (TG) did not 
prevent CSD evoked TCC activity (Lambert et al., 2011).  Furthermore, imaging data indicate 
that activity in the brainstem correlates with the presence of pain during a migraine (Akerman et 
al., 2011).  
However, there are problems with each of these lines of evidence.  Most problematic is 
that while it is clear that there are changes in the CNS of migraineurs (premonitory symptoms or 
CSD), or at least in the processing of sensory information, it is not clear how any of these 
changes can lead to pain that is largely localized in the head (Olesen et al., 2009).  Second, while 
recent evidence has confirmed that CSD can produce sensitization and activation of dural 
afferents (Zhang et al., 2010), there is compelling evidence against a necessarily causal link 
between aura and headache: 1) the aura can be aborted by dihydropyradines, but these 
compounds have no effect on the subsequent headache (Charles, 2010); 2) the headache can be 
aborted with a triptan or topiramate (Lampl et al., 2004, Wolthausen et al., 2009) but these drugs 
have no effect on the aura; 3) migrainuers with aura can have migraines without an aura as well 
as auras without migraine (Stewart et al., 1991, Charles, 2010); and 4) auras are only present in 
20-30% of migraineurs (Rasmussen and Olesen, 1992).  There is no evidence of “silent” auras 
(CSD wave across a cortically silent area) in migraine without aura patients.   
Third, descending facilitation is distributed widely across the TCC and length of the 
spinal cord, and at least based on what we know about this process, cannot account for the 
specificity of head pain during an attack.  And while widely championed by the proponents of 
the central theory of migraine, there were numerous technical problems with the Lambert study, 
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not the least of which was an incomplete and inadequately assessed block of the TG, but was 
covered in more detail by (Burstein et al., 2012).  Consequently, conclusions drawn from this 
study should be made with caution.  However, I acknowledge that it is possible that there is some 
resting level of activity in dural nociceptors that may be perceived as painful with changes in the 
CNS.  Finally, if disinhibition of the TCC was the mechanism for the initiation of pain, allodynia 
should be present from the very beginning of an attack.  Not only is there a delay between the 
start of the headache and the emergence of allodynia (Burstein et al., 2004), but allodynia does 
not occur in 21-37% of migraineurs (Burstein et al., 2000, Lipton et al., 2008).  Thus, a key point 
to the peripheral hypothesis of migraine pain is that while the brainstem modulates the activity of 
afferent input throughout the body through descending inhibition/facilitation, there is no 
evidence that the brainstem generates the focal changes that could specifically cause a migraine 
(or pain in any other specific area of the body). 
Due to the evidence outlined above in support of a peripheral origin of pain in migraine, 
and lack of evidence for a central origin, I chose to focus my dissertation research on 
mechanisms associated with migraine arising from the periphery.  In particular, I chose to focus 
on the factors that would account for the release of sensitizing inflammatory mediators to initiate 
a migraine in the first place.   
1.2 SEX DIFFERENCE AND GONADAL HORMONE REGULATION OF 
MIGRAINE 
As mentioned above, there is a clear sex difference in the prevalence of migraine.  Evidence in 
support of a link between gonadal hormones and migraine, particularly dynamic fluctuations in 
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estrogens, include the following: 1) the frequency and prevalence of migraine attacks increases 
with menarche and decreases with menopause (Neri et al., 1993, Brandes, 2006); 2) in about 
50% of female migraineurs, attacks are reported more frequently around menstruation, just after 
estrogen levels drop in the cycle (Brandes, 2006); 3) estrogen treatment given just before 
menstruation to prevent the drop in estrogen associated with menstruation can prevent menstrual 
migraine (Martin and Behbehani, 2006); 4) in a study of 98 women undergoing in vitro 
fertilization where estrogen levels were suppressed prior to ovarian hyperstimulation, estrogen 
suppression was associated with a spike in migraine attacks in 82% of the women (Amir et al., 
2005); and 5) when estrogen levels dramatically rise during pregnancy and do not drop, 
migraines improve in over 80% of migraineurs by the second trimester and 53% and 79% had 
complete remission during the second and third trimesters, respectively (Sances et al., 2003).   
There are several lines of evidence suggesting that estrogen may influence nociceptive 
processing through an action on the primary afferent.  First, estrogen receptors are present in 
both dorsal root ganglion (DRG) and TG neurons (Taleghany et al., 1999, Bereiter et al., 2005, 
Puri et al., 2006), providing a potential substrate for pain modulation in the peripheral nervous 
system.  In DRG neurons, messenger RNA (mRNA) for estrogen receptor α (ERα) is localized 
almost exclusively in small diameter (putative nociceptive) neurons while estrogen receptor β 
(ERβ) is present in all sensory neurons (Taleghany et al., 1999).  Second, Martin and colleagues 
found enhanced sensitization of TNC neurons during stages of the rat estrous cycle immediately 
following abrupt drops in estrogen (Martin et al., 2007).  The excitability of primary afferents in 
the trigeminal system have been shown to be modulated by estrogen levels (Cairns et al., 2001), 
with evidence from our lab indicating that estrogen replacement in ovariectomized rats results in 
a significant increase in the excitability of afferents innervating the temporomandibular joint 
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(Flake et al., 2005).  More relevant to migraine, our lab has also demonstrated that a significantly 
greater proportion of dural afferents from female rats are sensitized by inflammatory mediators 
than those from male rats (Scheff and Gold, 2011).  Lastly, the threshold for CSD was 50% 
lower in female mice than males (Brennan et al., 2007).  In a genetic model of familial 
hemiplegic migraine, R192Q knock-in mice had an increased susceptibility to CSD.  This 
phenotype was stronger in females, abrogated by ovariectomy and restored by estrogen 
replacement (Eikermann-Haerter et al., 2009b).  In contrast, orchiectomy increased CSD 
susceptibility in males and testosterone replacement restored the phenotype (Eikermann-Haerter 
et al., 2009a). 
Due to evidence outlined above that pro-inflammatory processing as well as afferent 
activation is different in females compared to males, and that this is inherently important to the 
manifestation of this disorder, I chose to study mechanisms that may contribute to the initiation 
of migraine in both females and males.   
1.3 STRESS AS A MIGRAINE TRIGGER 
The physiological concept of “stress” has developed over the last century largely as a result of 
the pioneering work of Claude Bernard, Walter Cannon, and in particular Hans Selye.  
Organisms survive by maintaining a complex and dynamic state of internal balance, or 
homeostasis.  Stressors are now largely viewed as perceived endogenous or exogenous 
challenges which may threaten homeostasis.  The body reacts to stressors by activating the 
sympathoadrenal (SA) and hypothalamic-pituitary-adrenocortical (HPA) axes to generate a 
coordinated response to maintain homeostasis (stress response) (de Kloet et al., 2005, Ulrich-Lai 
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and Herman, 2009, Lucassen et al., 2014).  The first phase of the stress response is often referred 
to as the “fight or flight” response, and involves the rapid activation two branches that make up 
the SA axis.  One branch consists of sympathetic nervous system activation, where sympathetic 
post-ganglionic neurons (SPGNs) that innervate peripheral tissues release norepinephrine (NE) 
locally.  The second branch consists of sympathetic activation of the adrenal medulla, and 
subsequent release of epinephrine and NE into the general circulation.  Together, this release 
quickly elevates metabolic rate, blood pressure, respiration, and directs blood flow to vital 
tissues, such as the heart and skeletal muscles, that are critical for a fight or flight reaction 
(Ulrich-Lai and Herman, 2009, Lucassen et al., 2014).  The second phase of the stress response 
involves activation of the HPA axis, which is triggered by corticotropin-releasing hormone 
(CRH) from the paraventricular nucleus of the hypothalamus.  CRH induces adrenocorticotropic 
hormone release from the pituitary, which in turn drives the release of glucocorticoid hormones 
(GCs) from the adrenal cortex.  GCs (corticosterone in rodents and cortisol in humans) generally 
act more slowly as genomic transcriptional regulators, but can also act more quickly via 
membrane-bound receptors to coordinate tissue/cell functions that are geared towards coping 
with stress, recovery and adaptation, such as mobilizing substrates for energy metabolism.  
While these processes are complementary to that initiated with the activation of the SA axis, GCs 
also dampen primary SA axis stress and pro-inflammatory immune cell activation to prevent 
overshooting.  Regulation of the HPA axis response occurs through GC-mediated negative 
feedback on the hypothalamus and pituitary (de Kloet et al., 2005, Ulrich-Lai and Herman, 2009, 
Lucassen et al., 2014).   
Acute stress is analgesic in healthy animals and humans.  The most common anecdotal 
evidence of this comes from soldiers wounded in battle and athletes injured in games, who report 
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less pain in the heat of the action.  These anecdotes have been confirmed in the laboratory 
setting, where significant increases in both pain threshold and tolerance have been documented, 
and are mediated by activation of descending inhibition (Butler and Finn, 2009).  While the pre-
clinical literature on acute stress is extensive, there are two features of the stress response that 
may be of particular relevance of this dissertation.  First, the nature of the response depends on 
the nature of the stressor.  A dramatic example of this would be the set of parameters that 
produce opioid-dependent and opioid-independent stress-induced analgesia (Mogil et al., 1996), 
suggesting that there are not only quantitative differences in the response to stress, but qualitative 
differences in the neural circuitry engaged.  Second, the response to stress is sexually dimorphic.  
For example, the parameters that produce an opioid-dependent stress-induced analgesia in male 
rodents, result in an opioid-independent stress-induced analgesia in females (Mogil et al., 1993). 
While the response to acute stress is generally considered adaptive, the response to 
chronic or repeated, non-habituating stress is generally considered maladaptive.  Chronic stress 
blunts the body’s underlying acute responses to stress through down-regulation of GCs, and 
ultimately can lead to hyperalgesia.  In animals, models of repeated cold stress, repeated swim 
stress and chronic restraint stress have been shown to produce mechanical and thermal 
hyperalgesia (Imbe et al., 2006, Jennings et al., 2014).  Numerous possible mechanisms for the 
chronic stress-induced hyperalgesia have been identified, including alterations in the HPA axis 
reactivity, neurotransmitter release in the CNS as well as increased glutamate release from 
primary afferents in the spinal cord and dysregulation of the immune system in the PNS (Imbe et 
al., 2006, Jennings et al., 2014).   
The most common trigger for migraine is stress.  Approximately 76% of migraineurs 
report that their attacks have triggers, and 80% of these report stress as a common trigger 
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(Kelman, 2007) and 58% report it as their main trigger (Zivadinov et al., 2003).  Stress also 
amplifies attack intensity (Chabriat et al., 1999) and duration (Wacogne et al., 2003).  
Furthermore, many of the other common triggers for migraine such as alterations in sleep/wake 
cycle, skipping meals, dehydration, caffeine or alcohol consumption, and hormonal variation 
across the menstrual cycle (Sauro and Becker, 2009) are all physiological stressors that can 
impact both the HPA and SA axes.  In many pain syndromes, such as irritable bowel syndrome 
(Larauche, 2012, Larauche et al., 2012, Myers and Greenwood-Van Meerveld, 2012), interstitial 
cystitis (Theoharides et al., 1998), fibromyalgia (McEwen and Kalia, 2010) and rheumatoid 
arthritis (Wood, 2009), both acute and chronic stress exacerbate symptoms during the stress.  In 
contrast, migraine has a unique temporal dynamic in response to stress.  Attacks often occur 
during the relaxation phase after stress, up to 24 hours following the removal of stress.  These 
observations lead to the “stress-relaxation model” of migraine, and such headaches have been 
called “let-down headaches” (Hering et al., 1992, Spierings et al., 1997, Torelli et al., 1999, 
Hashizume et al., 2008, Lipton et al., 2014).  Both acute stressors, such as GTN, alcohol, or 
skipping meals, as well as chronic stressors such as an intense workweek, studying for an 
exam/presentation, or illness in the family, often trigger migraines, but with a delay after the 
termination of the stress (i.e., 4 hrs after GTN, “weekend migraines,” or the evening/morning 
after an exam/presentation).  While there is a clear link between the timing of stress and 
migraine, the exact relationship can become complicated in humans.  For example, in one study 
70% of migraineurs reported attacks after the resolution of stress, but 60% also reported attacks 
during stress (Hauge et al., 2010).  However, among these patients, commonly reported stressors 
were “marital problems” and “economic problems”—stressors that do not create a clear 
resolution of stress and relaxation phase.  Stressors that produce a large increase in stress and 
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clear relaxation following removal of the stressor are commonly reported to result in “let-down” 
migraines. 
Due to the prevalence of stress as a trigger for migraine, I have chosen to study how 
stress may contribute to inflammatory processing in the dura and thus the initiation of an attack.  
Furthermore, due to the unique temporal dynamic between stress and the start of a migraine 
attack, I have studied in particular whether the delay following stress may provide insights 
regarding the mechanisms involved in attacks.   
1.4 EVIDENCE OF A SPGN CONTRIBUTION TO MIGRAINE PAIN 
There is evidence of sympathetic dysregulation in migraineurs, indicating alterations in the SA 
axis and specifically SPGNs.  The majority of clinical data evaluating sympathetic function in 
migraineurs indicate sympathetic hypoactivity with secondary adrenergic receptor (AR) 
supersensitivity.  A consistent finding is that migraineurs have significantly lower supine plasma 
NE levels between attacks than age and sex matched controls, pointing to sympathetic 
hypoactivity.  In five published reports with a total of 113 migraineurs, NE levels were 61% of 
controls (Peroutka, 2004).  NE and blood pressure changes remained impaired in migraineurs 
when challenged with a physiological sympathetic-activating task.  For example, with orthostatic 
changes (standing up or head-up tilt) the resulting rapid increase in plasma NE levels remained 
significantly lower (59% of controls), and the decrease in both systolic and diastolic blood 
pressure was greater than controls in three published reports (Peroutka, 2004).  Other 
sympathetic tests such as isometric exercise (sustained handgrip test), cold pressor test, and 
Valsalva maneuver were also impaired.  The normal response to these tests—an increase in heart 
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rate and blood pressure—was significantly lower in migraineurs than in controls (Peroutka, 
2004).  Clinical studies have also recorded pupil size, which is under direct tonic control of both 
the sympathetic and parasympathetic post-ganglionic neurons, regulating pupil dilation and 
constriction, respectively.  Significantly smaller pupils have been reported in 5-20% of 
migraineurs during interictal periods, again indicating SPGN hypoactivity (Herman, 1983, 
Drummond, 1991).  Furthermore, an oral dose of fenfluramine, which releases NE stores from 
nerve terminals, resulted in decreased pupil dilation compared to controls, and pupils were still 
significantly smaller up to 8 hours after application, suggesting that migraineurs may have 
smaller NE stores (Fanciullacci, 1979).  Guanethidine application, which disrupts NE vesicle 
release from SPGNs, resulted in a greater and longer lasting constriction of pupils in migraineurs 
than controls, suggesting that NE resynthesis may also be impaired (Fanciullacci, 1979).   
Additional pharmacological tests and prophylactic treatments further point to AR 
supersensitivity, possibly as a compensatory change in receptors on SPGN targets in response to 
the sympathetic hypofunction.  For example, the resulting increases in blood pressure and heart 
rate to an intravenous bolus injection of NE or phenylephrine (α1-AR agonist) were significantly 
greater and longer lasting in migraineurs than controls (Gotoh et al., 1984, Boccuni et al., 1989).  
Also, during interictal periods, migraineurs had significantly increased pupil dilation following 
epinephrine or phenylephrine eye drops than controls (Fanciullacci, 1979, Fanciullacci et al., 
1982, Gotoh et al., 1984, Drummond, 1991).  Finally, one class of effective prophylactic 
treatments for migraine include drugs that act on the sympathetic system—in particular beta-
adrenergic antagonists (β blockers) (Rapoport and Bigal, 2005).  The efficacy of this treatment 
would support post-synaptic β-AR supersensitivity.   
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Several lines of preclinical evidence also pointed to the possibility of a link between 
SPGN and migraine.  First, we (Harriott and Gold, 2008, McIlvried et al., 2010) and others 
(Keller et al., 1989) have described extensive innervation of the dura by SPGNs, which closely 
associate with dural afferents and vasculature as well as extravascular areas (Appendix A).  In a 
mouse model of familial hemiplegic migraine, in which the wild-type P/Q type voltage-gated 
Ca2+ channel has been replaced with the R192Q mutant channel, I have found increased SPGN 
innervation of the dura (Appendix B).  Additionally, our lab has previously shown that dural 
SPGNs contain the 5HT1D receptor, the target of triptans, which are the most effective acute 
treatment for migraine.  Second, the possibility that SPGNs in the dura may directly influence 
dural afferent activity is suggested by the fact that SPGNs release a number of compounds that 
can activate and/or sensitize dural afferents.  These include neurotransmitters (NE, NPY, ATP) 
subject to vesicular release and PGE2, synthesized and released on demand (Straub et al., 2006).  
Our lab has shown that application of PGE2 (either individually or in an inflammatory soup also 
containing histamine and bradykinin) to dissociated dural afferents results in an increase in 
excitability (Vaughn and Gold, 2010).  Recently, NE application to dural afferents has also been 
shown to increase excitability (Wei et al., 2015).  In dorsal root ganglion neurons, ATP has been 
well established to induce excitability (Burnstock, 2007, Dussor et al., 2008).  
Third, the possibility that SPGNs in the dura may indirectly influence dural afferent 
activity is suggested by evidence that SPGNs can facilitate an inflammatory response.  I have 
shown that dural SPGNs may regulate, at least in part, stress-induced mast cell degranulation and 
protein plasma extravasation in the dura (Appendix C), thereby contributing to an inflammatory 
response.  Also, in an ex vivo dura preparation, Ebersberger and colleagues showed that NE can 
increase the release of PGE2 (Ebersberger et al., 2006).  Further evidence of SPGN facilitation of 
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inflammation has been demonstrated in other tissues.  For example, in the skin, the inflammatory 
mediator bradykinin (BK) induced SPGN dependent release of PGE2, resulting in mechanical 
hyperalgesia (Taiwo and Levine, 1988, Khasar et al., 1995).  Also, in the knee joint, SPGN 
innervation was essential for the neurogenic inflammatory response (Green et al., 1999, Hucho 
and Levine, 2007).   
Due to evidence outlined above that SPGNs are activated during stress and may directly 
or indirectly contribute to dural afferent activity, I chose to additionally study the impact to 
which SPGNs in particular regulate inflammatory responses in the dura, and thus migraine pain.  
1.5 IMMUNE SYSTEM CONTRIBUTION TO MIGRAINE PAIN 
One way sex, stress and SPGNs may impact migraine pain is through regulation of the immune 
system.  Innate and adaptive immune responses require activation of immune cells (white blood 
cells, or leukocytes).  Innate immunity, the first line of defense and non-specific response, 
largely involves myeloid-derived granulocytes, macrophages, mast cells, and dendritic cells 
which are recruited to sites of inflammation from the blood.  Granulocytes, whose prominent 
granules give them characteristic staining patterns, include neurotrophils, eosinophils and 
basophils.  In the acute phase of an inflammatory response, neutrophils are normally the earliest 
and most numerous cell type to infiltrate tissue.  They are phagocytic, and release a variety of 
pro-inflammatory mediators, including ones that attract other immune cells such as 
macrophages.  Eosinophils and basophils are thought to play more of a role in parasitic infections 
(Murphy, 2011).  Macrophages are a key phagocytic cell.  Their main function is to phagocytose 
foreign material, microbes, and other leukocytes to remove injured and dying tissue debris.  They 
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also release a variety of pro-inflammatory mediators (Murphy, 2011).  Mast cells also 
differentiate in tissue and mainly distribute near blood vessels.  When stimulated, they 
degranulate and release pro-inflammatory mediators, contributing to inflammation and vascular 
permeability.  They are classically known for their role in allergic reactions (Murphy, 2011).  
Dendritic cells, in an immature state, are both phagocytic and macropinocytic.  However, when 
encountering a pathogen they are specialized to take up antigen, rapidly mature, and migrate to 
lymph nodes to display it for recognition by T lymphocytes, thereby activating the adaptive 
immune response (Murphy, 2011).  Lastly, lymphoid-derived natural killer cells are also 
considered part of the innate immune system because they lack antigen receptors.  These cells 
largely circulate in the blood, and recognize and kill abnormal cells such as tumor and virus-
infected cells (Murphy, 2011).   
Adaptive immune responses involve activation of lymphoid derived B- and T-
lymphocytes, which provide the long-term, specific immunity that can follow exposure to a 
pathogen.  T-cells will recognize antigens expressed by antigen presenting cells (dendritic cells, 
B-cells, or host cells), and will mount the appropriate response.  There are multiple subsets of T-
cells, and the type of antigen expressed will determine the class of T cell activated and response 
generated.  Cytotoxic T cells kill cells infected with viruses, where helper T cells induce a Th1 or 
Th2 type response.  The Th2 response is characterized by the production of cytokines facilitating 
“cell-mediated immunity” (immune responses that do not involve antibodies, such as 
phagocytoic cells, natural killer cells, cytotoxic T-cells).  The Th2 response supports antibody 
production (Murphy, 2011).  More important for this dissertation is to note that processes that 
facilitate a shift from Th2 to Th1 are pro-inflammatory (Chapman et al., 2008).  Regulatory T 
cells have been identified as negative regulators of adaptive immunity.  They suppress aberrant 
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responses to self-antigens, and are more important in controlling autoimmune diseases.  Lastly, 
when activated, B-cells differentiate into plasma cells that secrete antibodies to a specific 
antigen.  These antibodies bind to the antigen, “flagging” them for phagocyotic cells.  Some 
plasma cells become memory B cells, which survive to respond efficiently if the specific antigen 
is ever encountered again.  Together the innate and adaptive immune systems provide an 
effective defense system (Murphy, 2011).  While this brief overview does not begin to touch on 
the complexity of the immune system, it highlights some of the traditional types and roles of 
immune cells that are examined in this dissertation.   
I hypothesized that immune cells may contribute to an inflammatory response in the dura, 
and therefore initiation of a migraine attack for multiple reasons.  First, immune cells are a 
primary source of pro-inflammatory mediators.  As noted previously, migraineurs have increased 
levels of pro-inflammatory mediators in their plasma and CSF during attacks, including the 
immune cell mediators IL-6, TNFα, and IL-1β (Perini et al., 2005, Fidan et al., 2006, Sarchielli 
et al., 2006).  Second, stimuli that trigger migraines can activate immune cells.  For example, 
stress [Appendix C and (Theoharides et al., 1995)], GTN (Reuter et al., 2001), and CSD (Karatas 
et al., 2013) can degranulate dural mast cells, and GTN can drive an upregulation of inducible 
NOS (iNOS) and IL-6 in dural macrophages (Reuter et al., 2001).  Third, activation of immune 
cells can increase excitability of dural afferents.  Degranulation of resident dural mast cells with 
the basic secretagogue agent compound 48/80 was sufficient drive dural afferent activation, 
which could be blocked with the mast cell stabilizer sodium cromoglycate (Levy et al., 2007).  
Fourth, immune cell pro-inflammatory mediators, such as IL-6 and TNFα can activate dural 
afferents.  IL-6 has been shown to directly activate dissociated dural afferents (Yan et al., 2012), 
while TNFα mediated sensitization is indirect (Zhang et al., 2011).  Zhang and colleagues 
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showed that TNFα application to the dura and consequent sensitization of dural afferents 
required activation of vascular endothelial cells and macrophages in the dura, and subsequent 
release of pro-inflammatory COX-derived prostanoids (Zhang et al., 2011).  
I also chose to focus on immune cells in this dissertation due to evidence indicating that 
immune cells are regulated by factors that are also features of migraine: 1) the sex-difference and 
regulation by gonadal hormones, 2) attacks triggered by stress, 3) and sympathetic dysregulation.  
First, most major subtypes of immune cells have been shown to express estrogen (and other sex 
steroid hormone) receptors, and there are complex sex differences and hormone responses on 
immune cell number and activation (Oertelt-Prigione, 2012, Pennell et al., 2012, Yakimchuk et 
al., 2013).  For example, females were reported to have more resident immune cells in the 
peritoneal cavity compared to males (Scotland et al., 2011).  Also, in cycling females during the 
luteal phase when menstrual migraines occur, there were increased total monocyte (Mathur et al., 
1979, Northern et al., 1994) and neutrophil (Jiemtaweeboon et al., 2011) numbers circulating in 
the blood.  The low levels of estrogen during this phase stimulate increased TNFα release from 
monocytes (Brannstrom et al., 1999) and T cells (Correale et al., 1998).  Low levels of estrogen 
are described to generally facilitate Th1 (pro-inflammatory) responses (Pernis, 2007, Oertelt-
Prigione, 2012, Pennell et al., 2012).  Ultimately, sex differences depend not only on genetic, 
hormonal and hormone receptor levels, but how immune cells are modulated by these factors 
during proliferation in the bone marrow and spleen, density and phenotype in the blood, 
trafficking to peripheral tissues, and ultimately their function within the tissue.  In the dura 
specifically, it has been shown that mast cells express estrogen receptors (Rozniecki et al., 1999) 
and a combined estrogen and progesterone treatment following ovariectomy augmented mast cell 
degranulation (Boes and Levy, 2012).  Also, dural mast cell density was increased in females, 
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which fluctuated with estrous cycle (highest at diestrus) and was dependent upon estrogen levels 
(Boes and Levy, 2012). 
Second, it is well known that the immune system is dramatically influenced by stress.  
Stress can affect the immune system by multiple pathways—the HPA axis via CRH and GC 
receptors on immune cells and the SA axis via ARs on immune cells (see below).  Lymph nodes 
are also directly innervated by SPGNs (Glaser and Kiecolt-Glaser, 2005, Chapman et al., 2008, 
Webster Marketon and Glaser, 2008, Rohleder, 2012, Reader et al., 2015).  Generally, acute 
stress has been shown to be immune-enhancing while chronic stress is immunosuppressive.  
Chronic stress has been shown to delay wound healing and enhance the risk and prolong the 
duration of an infectious disease (Glaser and Kiecolt-Glaser, 2005, Chapman et al., 2008, 
Webster Marketon and Glaser, 2008, Rohleder, 2012, Reader et al., 2015).  HPA-axis GCs 
down-regulate inflammation by binding to their cytoplasmic receptors and inducing translocation 
to the nucleus where the complex interferes with the DNA-binding activity of the major 
inflammatory transcription factor NF-κβ (McKay and Cidlowski, 1999).  This mechanism has 
been therapeutically exploited for decades, as steroids are prescribed as potent anti-inflammatory 
drugs.   
Third, immune cells also express ARs, which can regulate their proliferation, chemotaxis 
and activation in response to epinephrine and NE (Vizi, 1998, Elenkov et al., 2000).  For 
example, β- and α-ARs can differentially suppress and facilitate, respectively, pro-inflammatory 
cytokine production in macrophages (Ignatowski et al., 1996, Szelenyi et al., 2000).  
Furthermore, there is evidence of time-dependent shifts in macrophages (Ignatowski et al., 1996) 
and T-cells (Sanders, 2012) and sexually dimorphic regulation of ARs in T-cells (Leposavic et 
al., 2008) and NK cells (Shakhar et al., 2000).  Neutrophil number and chemokinesis is also 
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regulated by stress and β-ARs in a sexually dimorphic manner (de Coupade et al., 2004, Barker 
et al., 2005).  Additionally, it has been hypothesized that whether the cell is already activated is 
important.  Evidence suggests that AR signaling can suppress an inflammatory response in 
already activated immune cells, but can induce an inflammatory response in non-activated 
immune cells (Rohleder, 2012).   
In this Introduction I have briefly reviewed the clinical features of migraine as well as 
some of the most relevant data regarding the neurobiology of migraine, at least in support of a 
peripheral origin of migraine pain.  I have summarized evidence in support of the biological 
basis for the sex difference in the manifestation of migraine.  I briefly summarized some of the 
critical features of a stress response, the link between stress and pain and the evidence in support 
of an important but unique link between stress and migraine.  I also summarized evidence in 
support of a link between dural SPGNs and migraine.  Finally, I again briefly described key 
features of the immune system, as well as evidence that dural immune cells are uniquely 
positioned to not only account for the key clinical features of migraine that I summarized, but to 
serve as the penultimate mediators of a migraine attack.  This evidence served as the basis for the 
central hypothesis of my thesis research, which is that stress drives sex- and SPGN-dependent 
changes in the regulation of dural immune cells, setting the stage for the initiation of a migraine 
attack. 
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2.0  SEX-, STRESS-, AND SYMPATHETIC POST-GANGLIONIC-DEPENDENT 
CHANGES IN THE IDENTITY AND PROPORTIONS OF IMMUNE CELLS IN THE 
DURA 
Due to compelling evidence in support of links between sex, stress, sympathetic post-ganglionic 
innervation, dural immune cells, and migraine, our aim was to characterize the impact of these 
factors on the type and proportion of immune cells in the dura.  Dural immune cells were 
obtained from naïve or stressed adult male and female Sprague Dawley rats for flow cytometry.  
Rats with surgical denervation of sympathetic postganglionic neurons (SPGNx) of the dura were 
also studied.  Immune cells comprise ~17% of all cells in the dura.  These were comprised of:  
macrophages/granulocytes (Macs; 63.2% of immune cells), dendritic cells (0.88%), T-cells 
(4.51%), natural killer T-cells (0.51%), natural killer cells (3.08%), and B-cells (20.0%).  There 
were significantly more Macs and fewer B-and natural killer T-cells in the dura of females 
compared to males.  Macs and dendritic cells were significantly increased by stress in males, but 
not females.  In contrast, T-cells were significantly increased in females with a 24 hr delay 
following stress.  Lastly, Macs, dendritic cells, and T-cells, were significantly higher in SPGNx 
naïve males but not females.  It may not only be possible, but necessary to use different 
strategies for the most effective treatment of migraine in men and women. 
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2.1 INTRODUCTION 
Evidence suggests that a “sterile” inflammation of the dura is responsible for the activation and 
sensitization of dural afferents thought to be responsible for migraine pain (Waeber and 
Moskowitz, 2005, Olesen et al., 2009, Levy, 2012).  However, the mechanisms underlying the 
initiation of the inflammation are poorly understood.  One mechanism may be via dural immune 
cells.  Consistent with this possibility, there is evidence that degranulation of resident mast cells 
is sufficient to drive the activation and sensitization of dural afferents (Levy et al., 2007) and that 
a migraine inducing stimulus, glyceryl trinitrate (GTN), can drive the degranulation of dural 
mast cells, and an upregulation of inducible NOS (iNOS) and IL-6 mRNA in dural macrophages 
(Reuter et al., 2001).  
While the extent to which other immune cell types may contribute to migraine remains to 
be determined, the clinical manifestations of migraine suggest several additional reasons to focus 
on dural immune cells as an underlying contributor to this neurological disorder.  First, the 
prevalence of migraine is roughly three times higher in women than in men (Pietrobon and 
Striessnig, 2003).  That immune cells may contribute to this sex difference is suggested by the 
observations that there are sex differences in immune cell number, phenotype, and expression of 
hormonal receptors (Pennell et al., 2012, Sankaran-Walters et al., 2013, Yakimchuk et al., 2013).  
Second, roughly 80% of migraineurs report stress as a trigger for a migraine attack and 60% 
report it as their main trigger (Martin, 2010).  Stress also amplifies attack intensity and duration 
(Sauro and Becker, 2009).  The link between stress and migraine has an important and 
interesting temporal dynamic.  Formally referred to as the “stress-relaxation model”, it has been 
proposed that a migraine attack occurs during the relaxation phase after stress (Sauro and 
Becker, 2009).  And while there is evidence linking immune cells to the acute exacerbation of 
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pain observed in other pain syndromes (Theoharides et al., 1998, Wood, 2009, McEwen and 
Kalia, 2010, Larauche, 2012, Larauche et al., 2012), there is also evidence to suggest that time 
dependent changes in the regulation of immune cells could account for the delay in the migraine 
attack after the resolution of the stressor.  For example, almost all immune cells express 
adrenergic receptors (AR), and β- and α-ARs differentially suppress and facilitate, respectively, 
pro-inflammatory cytokine production (Ignatowski et al., 1996, Szelenyi et al., 2000).  
Furthermore, there is evidence of time-dependent shifts (Ignatowski et al., 1996, Sanders, 2012) 
and sexually dimorphic regulation (Shakhar et al., 2000, de Coupade et al., 2004, Barker et al., 
2005, Leposavic et al., 2008) of ARs on immune cells.  Third, there is evidence of sympathetic 
dysregulation in migraineurs, which includes a) lower plasma norepinephrine levels between 
attacks than is observed in non-migraineurs; b) impaired sympathetic responses to challenge (i.e., 
pressor responses); and c) AR hypersensitivity, possibly secondary to the sympathetic 
hypofunction (Peroutka, 2004).  There also is evidence that α-AR agonists and β-AR antagonists 
can decrease the frequency of migraine attacks (Goadsby and Sprenger, 2010).  Finally, the link 
between these clinical features of migraine and immune cells is suggested by the observations 
that stress is associated with the activation of both the hypothalamic-pituitary-adrenal and the 
sympatho-adrenal axes, the dura is heavily innervated by sympathetic post-ganglionic neurons 
(SPGNs) (Keller et al., 1989, Harriott and Gold, 2008), and immune cells are under AR 
regulation.  
Despite this compelling evidence in support of a link between dural immune cells and 
migraine, there have been no systematic analyses of the immune cells in the dura, let alone 
studies to address sex differences in these immune cells, and/or stress-induced changes in these 
immune cells that would be consistent with a role in migraine.  To begin to address this issue, we 
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have performed a detailed characterization of the immune cells in the dura of male and female 
rats.  The impact of stress was assessed by comparing immune cells in naïve rats to those 
immediately, or with a delay, following the termination of chronic stress.  Finally, to determine 
whether local SPGN signaling may contribute to dural immune cell regulation, naïve and 
stressed rats were studied following SPGN denervation of the dura. 
2.2 METHODS 
2.2.1 Animals 
Pathogen free adult (P50-70) male (200-300g) and female (150-250g) Sprague-Dawley rats 
(Harlan Sprague-Dawley, Indianapolis, IN) were used for all experiments.  Rats were housed in 
pairs in microisolator cages [(Allentown Caging Equipment Co., Inc., Allentown, NJ), bedded 
with certified Aspen Coarse-grade Sani-chips® (P.J. Murphy Forest Products Corp, Montville, 
NJ)] in the University of Pittsburgh Association for the Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) approved animal facility on a 12:12 light:dark cycle at 
72°F with food [ProLab® IsoPro® RMH 3000 5P76 irradiated (LabDiet, St. Louis, MO)] and 
water available ad lib unless indicated.  Environmental enrichment was not provided, as it would 
counter-act the study of stress.  All procedures were approved by the University of Pittsburgh 
Institutional Animal Care and Use Committee and performed in accordance with National 
Institutes of Health Guide for the Care and Use of Laboratory Animals. 
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2.2.2 Chronic variable stress (CVS) 
Animals were exposed to chronic variable stress (CVS), consisting of an ongoing series of 
“mild” stressors applied for variable durations over a period of 4 days (see experimental design 
in Figure 1A).  The paradigm was adapted from unpredictable chronic mild stress models of 
depression (Grippo et al., 2004), and was compressed from 3 weeks to 4 days.  This allowed us 
to model the length of stressors that typically trigger migraines (i.e., stress from a workweek or 
studying for an exam).  The presentation of many different kinds of stressors for different lengths 
of time over the 4 days allowed us to mimic a more complex, non-habituating stress.  
Additionally, with stressors presented constantly (as opposed to “repeated” chronic stress models 
where one stressor is presented for a short period of time for multiple days), this design allowed 
us to model the constant stress that typically triggers a migraine, as well as create a clear 
“relaxation period” following the stress during which migraines typically occur. 
After arrival, rats were housed in a “home” room for at least 6 days, and subsequently 
subjected to CVS in a separate, isolated housing room.  Rats were single-housed, an average of 2 
stressors were presented at any given time, and each stressor was presented twice over the 4 
days.  The schedule was semi-randomized to ensure that the same stressors were not always 
paired together or back-to-back.  Nine different stressors were used and these included: food 
deprivation (12-16 hrs each), water deprivation (12-16 hrs each), overnight illumination (no 12hr 
dark cycle), cage tilt (18° angle, 8-16 hrs, once on each of the short and long cage axis), paired 
housing with a stranger (8-16 hrs each), damp bedding (12-16 hrs each), white noise (85dB of 
white noise, 3-5 hrs each), strobe light (1 Hz, 4-6 hrs each), and predator odor (two 5cm2 pieces 
of cloth from predator cages were hung in rat cages, 30 min ferret odor once and 1 hr cat odor 
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once).  Rats with a delay period of “relaxation” after CVS were returned to the home housing 
room for that time. 
It is important to note we are not proposing that CVS is a model of migraine, nor do we 
anticipate that this stress paradigm causes migraine in rats.  Rather we have proposed to study 
changes in response to stress because we hypothesize that these changes may contribute to the 
initiation of a migraine attack in migraineurs. 
2.2.3 Bilateral superior cervical ganglion sympathectomy (SPGNx) 
One week prior to any experimentation, select animals underwent bilateral surgical removal of 
superior cervical ganglia (SCG), the cell bodies giving rise to sympathetic innervation of the 
dura (Figure 1A).  Animals were deeply anesthetized with an intraperitoneal (IP) injection of 
anesthetic cocktail [55 mg/kg ketamine (Fort Dodge, Fort Dodge, IA), 5.5 mg/kg xylazine 
(LLOYD, Shenandoah, IA), and 1.1 mg/kg acepromazine (Butler Schein, Dublin, OH)], and 
monitored by respiratory rate and responses to toe pinch.  SCG were accessed via a midline 
incision through the skin overlaying the trachea followed by blunt dissection of the muscles and 
connective tissue on either side of the trachea.  Following excision of the ganglia and visual 
confirmation of hemostasis, the incision site was closed.  Prior to recovery from anesthesia, rats 
received an intramuscular (IM) injection of buprenorphine (0.03 mg/kg; Reckitt Benckiser 
Pharmaceuticals, Richmond, VA).  Sham animals underwent the same procedures, except the 
SCG were not removed.  Animals were monitored daily following both surgical procedures. 
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2.2.4 Isolation of dural cells 
Tissue was collected from animals between 8-10am in the laboratory for CVS groups, and in a 
procedure room of the animal housing facility for naïve groups to minimize “transport stress.”  
Prior to dural tissue collection, animals were deeply anesthetized with pentobarbital (60mg/kg 
IP; Sigma, St. Louis, MO; an anesthetic with minimal effect on vascular tone or adrenergic 
receptors, potential confounds for our studies) followed by a rapid transcardiac perfusion with 
60mL cold 1x phosphate-buffered saline (PBS; pH 7.2).  If appropriate, the uterus was also 
collected and weighed as an indirect measure of estrus cycle (Ji et al., 2008).   
Following careful removal of occipital and parietal bones, dura extending from -4 to 
15mm (caudal to rostral of convergence of sinuses) and ±11mm (lateral) was collected and 
placed in 5mL of Dulbecco’s Modified Eagle Medium-F12+ [Advanced DMEM-F12 (Gibco, 
Grand Island, NY), to which 10 U/ml each of penicillin and streptomycin (Invitrogen, Carlsbad, 
CA), 5 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Calbiochem, San 
Diego, CA), and 2 mM L-glutamine (Invitrogen), were added] with 0.1% Collagenase P (Roche, 
Indianapolis, IN) in a sealed 60x15mm glass Petri dish and incubated for 1hr at 37°C in a 
shaking water bath.  Dura were then mechanically dissociated in this solution with fire-polished 
Pasteur pipettes, centrifuged at 250g, resuspended in 5 mL fresh DMEM-F12+, centrifuged 
again, and resuspended in 1mL staining media [(SM); Ca2+/Mg2+ free Dulbecco’s PBS (Lonza, 
Walkersville, MD), 3% heat inactivated newborn calf serum, 1mM EDTA 
(ethylenediaminetetraacetic acid), 0.02% sodium azide].  The final cell suspension was filtered 
through 50µm mesh (Sefar, Heiden, Switzerland) and subsequently processed for flow cytometry 
or FACS.  This protocol was adapted from (Borghesi et al., 2005, Steenhuis et al., 2008, Santos 
et al., 2014).  Cell viability was uniformly >80%. 
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2.2.5 Flow cytometry and fluorescence activated cell sorting (FACS) 
Flow cytometry and FACS, with the gating strategy illustrated in Figure 1B, was used to collect 
subpopulations of immune cells from each dissociated dura.  All cell processing was performed 
on ice with SM.  Initial cell counts were estimated with trypan blue staining.  Cells were first 
blocked with 10% rat serum for 10min to prevent non-specific binding of antibodies, 
resuspended in SM, and then incubated in primary antibodies for 20min.  They were then washed 
in SM 3 times prior to a final resuspension in 1µg/mL propidium iodide (PI; Molecular Probes, 
Eugene, OR) to exclude dead cells (viability), and immediately used for either flow cytometry or 
fluorescence activated cell sorting (FACS).  All primary antibodies were mouse monoclonal 
raised against rat epitopes from BD Biosciences (San Diego, CA), used at the following 
dilutions: APC cy7 CD45 (clone OX-1) 1:100, PEcy7 CD11b/c (clone OX-42) 1:50, V450 
CD11b (clone WT.5) 1:100, APC CD3 (clone 1F4) 1:50, PE CD161a (clone 10/78) 1:200, FITC 
CD45R (clone HIS24) 1:25.  Specificity of the antibodies has been previously documented 
(Taieb et al., 2007, Hara et al., 2012, Ozaki et al., 2012, Osborn et al., 2013).  Fluorescence 
minus one (FMO) antibody controls were used to identify negative staining in dural cells 
(Herzenberg et al., 2006).  Flow cytometry was performed on a 5 laser, 18 detector LSR Fortessa 
(BD Biosciences) and FACS was performed on a 3 laser, 11 detector FACS Aria (BD 










Figure 1.  Experimental design.   
(A) Intact and SPGNx, male and female rats were either considered “naïve” or exposed to constant, unpredictable, 
mild stressors over four days (chronic variable stress or CVS).  Tissue was collected from “naïve” rats, rats 
immediately after the last day of stress (“CVS+0h”) as a measure of the response to chronic stress, or rats after a 24 
hr delay after stress (“CVS+24h”) as a measure of the response to stress-relaxation. To test the impact of SPGN 
innervation, prior to stress superior cervical ganglia were surgically removed bilaterally (SPGNx) in appropriate 
groups.  On the left a representative whole mount dura from an adult rat 7 days after a unilateral SPGNx is shown, 
probed with anti-calcitonin gene-related peptide (CGRP, green) or anti-tyrosine hydroxylase (TH, red) antibodies.  
Note the complete loss of TH-like immunoreactivity (a marker for sympathetic fibers) ipsilateral to the SPGNx, but 
no change in CGRP-like immunoreactivity (a marker for peptidergic afferents).  (B) Gating strategy used for the 
isolation of immune cell subtypes from the dura.  Data shown are from a naïve male rat.  The day of the experiment, 
dural cells were dissociated and stained with antibodies specific to markers of immune cells and/or distinct immune 
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cell subtypes. The gating strategy illustrated was used for all flow and FACS experiments.  CD45+ immune cells 
were first selected, and then sorted into CD11b+ Macrophages/granulocytes/mast cells (Macs) and CD11c+ 
dendritic cells (DCs).  CD11b-/c- immune cells were further sorted into CD45R+ B-cells. CD11b-/c- and CD45R- 
immune cells were lastly sorted into either CD161a+ natural killer (NK) cells, CD3+ T-cells, and CD161a+/CD3+ 
NKT cells.  A small subset of immune cells were left unstained by any of the immune subtype antibodies utilized in 
this strategy (“unidentified”). Viability was uniformly 80-85%, as determined by PI and trypan blue staining.  This 
resulted in an average of 1.56 x 106 ± 0.18 x 106 live cells recovered per dura.  Spleen cells were used for 
compensation controls (Borghesi et al., 2005, Santos et al., 2014).  Images from FlowJo software, contour plots were 
used with 5% levels and outliers displayed. 
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2.2.6 Cell histology 
Dissociated dural cells from 6 male rats were pooled and sorted via FACS into 1x Ca2+/Mg2+ free 
PBS with 10% fetal bovine serum.  Sorted populations showed purities >97% on reanalysis. 
Each sorted cell population (CD11b+, CD11c+, CD3+, CD161a+ and CD45R+; see Figure 1B) 
was resuspended into a volume of 50uL/50,000 cells and cytocentrifuged (Cytospin 3; Shandon 
Lipshaw, Pittsburgh, PA) onto slides at 800rpm for 3min.  Slides were subsequently stained with 
the Diff Quik stain kit (Dade Behring, Newark, DE) or for 30sec with 1:1 of 1% toluidine blue 
(Sigma) in 70% EtOH : 1% NaCl pH 1.5.  Five randomized fields per slide were photographed 
under brightfield with a Leica DM4000B upright microscope and DFC300FX camera (Leica, 
Wetzlar, Germany).  Morphology and Diff quick staining was used to identify types of immune 
cells, and toluidine blue staining was used to identify mast cells.  Each micrograph was scored by 
an investigator blinded to the test population. 
2.2.7 Immunohistochemistry 
Following deep anesthesia with anesthetic cocktail, rats were transcardially perfused with 200-
250mL warm 1x PBS.  Dura were dissected, fixed for 10min in ice cold acetone (or methanol for 
mouse anti-rat CD3 antibody) and processed as free-floating whole-mounts.  Dura were 
incubated in blocking solution [10% normal donkey serum and 0.1% Triton X-100 in dilution 
buffer (1% BSA, 0.2% cold fish skin gelatin and 0.05% sodium azide in TBS)] for 1hr at room 
temperature, followed by the appropriate primary antibody in dilution buffer for 24 hrs at 4°C (or 
48 hrs for FITC mouse anti-rat CD45R antibody).  Primary antibodies were all raised in mouse 
 35 
and included: ED-2 1:500 (Serotec), CD3 (clone G4.18) 1:25 (BD Biosciences), and CD161a 
(clone 10/78) 5µg/mL (BD Biosciences).  Specificity of the antibodies has been previously 
documented (Brenan and Rees, 1997, Taieb et al., 2007, Zhang et al., 2009, Hara et al., 2012, 
Ozaki et al., 2012, Osborn et al., 2013).  Antibodies were visualized with donkey anti-mouse 
secondary antibodies conjugated to cyanine 2 (Jackson ImmunoResearch, West Grove, PA, 
USA) at 1:200 in dilution buffer for 2 hours at room temperature.   
To stain sensory and sympathetic fibers in the dura, rats were transcardially perfused with 
cold 1x PBS followed by cold 4% paraformaldehyde.  Dura whole-mounts were placed in 
blocking solution (10% normal donkey serum and 0.3% Triton X-100 in PBS) for 30 minutes 
and incubated in primary antibodies of rabbit anti-CGRP (Peninsula/Bachem, San Carlos, CA; 
1:500) and sheep anti-tyrosine hydroxylase (Millipore; 1:500) in blocking solution for 2 days at 
4°C.  Antibodies were visualized with donkey anti-sheep and donkey anti-rabbit secondary 
antibodies conjugated to cyanine 2 or 3 (Jackson) in blocking solution at 1:500 for 2 hours. 
Omission of primary antibody was used as a control for non-specific binding of the 
secondary antibody.  Dura were mounted on glass plus slides and coverslipped using 
Fluoromount-G (Southern Biotech).  Slides were photographed under epifluorescence with a 
Fluoview FV1000 confocal microscope (Olympus) and processed for brightness and contrast 
with Adobe Photoshop (Adobe Systems, San Jose, CA). 
2.2.8 Data analysis 
We tested four related a priori hypotheses based on clinical features of migraine.  The first 
hypothesis was that there are more immune cells in the dura of females than males.  The second 
hypothesis was that stress increases the relative proportion of dural immune cells with a delay 
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following the cessation of stress that is greater in females than males.  Thus, we examined the 
influence of both sex and stress on the proportion of immune cell subtypes in the dura by 
comparing naïve rats with rats exposed to 4 days of chronic variable stress (CVS), assessed 
either immediately following stress (CVS+0h) or with a 24 hr delay following stress (CVS+24h).  
The choice of a 24 hr delay was based on results from preliminary experiments also including a 
12 hr delay group (N=4 for both male and female).  No significant differences were detected 
between the 12 and 0 hr groups (data not shown), and thus the 12 hr delay group was not pursued 
further. 
The third hypothesis was that the proportion of dural immune cells are dependent on 
SPGN innervation, and more pronounced in females than males.  To test this hypothesis, we 
assessed changes in the proportion of dural immune cells in rats surgically sympathectomized 
(SPGNx) by removal of the superior cervical ganglion bilaterally.  Lastly, given that stress drives 
activity in the SPGN, our fourth hypothesis was that the stress-induced increase in dural immune 
cells in females is dependent on the presence of SPGN innervation.   
To address all four a priori hypotheses, rats were semi-randomized to groups in a 2x3x3 
design (Figure 1A) with groups defined by sex (male/female), stress (naïve/CVS+0h/CVS+24h), 
and SPGN innervation (intact/SPGNx/sham).  Rats were semi-randomized because they were 
assigned to groups by cages so that both rats in a cage were in the same group.  As it was only 
possible to process tissue from four rats per day, tissue from two groups were processed on any 
given day.  The order in which rats from any particular group were processed was also 
randomized.  The power analysis (G-power software, Softpedia) used to determine group size 
was based on preliminary analysis of CD11b+/c- cells from naïve males and females.  A group 
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size of six would enable us to detect a medium effect size of both sex and stress with a power of 
0.8 and alpha at 0.05. 
Immune cells from each animal were quantified with flow cytometry, and analyzed as a 
percent of total live cells so that changes in one subtype of immune cells could be determined 
independently of changes in another cell type.  Thus figures 4-7 are presented as a percent of 
total live cells, and normalized to the respective male naïve group for comparison. 
Data were analyzed with t-tests for sex effects (male vs. female), 2-way ANOVAs for sex 
and stress effects (naïve, 0, 12 or 24 hrs following CVS) as well as sex and SPGN effects (intact 
vs. SPGNx) in naïve animals, and 3-way ANOVAs for sex, stress, and SPGNs effects with 
p<0.05 considered significant.  The Tukey HSD test was used for post-hoc comparisons if 
significant interactions were detected.  An ANCOVA was used to assess the effect of estrus 
cycle with uterus weight as a rough measure of cycle stage. 
2.3 RESULTS 
This study was completed in two parts.  First we used flow cytometry to identify immune cell 
types present in the dura, and validated these data with complementary morphology following 
single cell sorting and IHC of intact dura.  Second, we used flow cytometry to determine the 
impact of sex, stress and SPGN innervation on the relative proportions of dural immune cell 
subtypes.  Any data related to this paper can be accessed by sending a request to the 
corresponding author. 
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2.3.1 Immune cell types present in the dura 
Flow cytometry, with the gating strategy illustrated in Figure 1B, was used to characterize 
immune cell types.  Within CD45+ leukocytes, six types of immune cells were detected (Figure 
2) as assessed using antibodies previously validated in the rat (Taieb et al., 2007, Hara et al., 
2012, Ozaki et al., 2012, Osborn et al., 2013).  In the naïve male dura, 63.2 ± 0.9% of immune 
cells in the dura were CD11b+ macrophages/monocytes, granulocytes and mast cells (“Macs”); 
0.9 ± 0.2% were CD11b/c+/CD11b- dendritic cells (“DCs”); 20.0 ± 0.1% were CD45R+ B-cells; 
3.1 ± 0.6% were CD161a+ natural killer (“NK”) cells; 4.5 ± 0.4% were CD3+ T-cells; and 0.5 ± 
0.1% were CD161a+/CD3+ natural killer T (“NKT”) cells.  An average of 7.8 ± 0.3% of immune 
cells were not specifically identified in our panel (“unidentified”).  The major subpopulations of 
immune cells were validated with morphological and histological analysis.  Diff quik staining 
(Figure 2, insets) confirmed that Macs consisted of 89.1% macrophages/monocytes with a 
characteristic and pronounced granularity, 5.1% neutrophils, 3.6% mast cells (identified with 
toluidine blue stain), and 2% contamination by lymphocytes.  The B-cell population consisted of 
93.0% small lymphocytes (≤10µm) and 5.1% large lymphocytes (>10µm), both of which were 
non-granular, with <2% contamination by macrophages/monocytes.  The NK cell population 
consisted of 51.3% large and 48.7% small lymphocytes, of low granularity.  The T-cell 





Figure 2.  Proportion of immune cell subtypes in the naïve male dura as determined with flow 
cytometry using the gating strategy shown in Figure 1B.   
Of the live cells recovered from the dura, an average of 16.9 ± 0.90% were CD45+, and thus determined to be 
immune cells. The pie chart and legend show the relative proportion of the 6 immune cell subtypes identified in the 
dura. The insets show FACS sorted, cytocentrifuged preparations of immune cell subtypes, subsequently stained 
with Diff quik. Macs consisted of 89.1% macrophages/monocytes (M), 5.1% neutrophils (N), 3.6% mast cells (MC; 
identified with toluidine blue stain), and 2.2% lymphocytes.  The NK cell population consisted of 51.3% large 
lymphocytes (>10µm) and 48.7% small lymphocytes (≤10µm).  The T-cell population consisted of 79.7% small 
lymphocytes and 20.3% large lymphocytes.  Lastly, the B-cell population consisted of 93.0% small lymphocytes, 
5.1% lymphocytes, and 1.9% macrophages/monocytes.  Scale bars 10µm. 
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To exclude the possibility that immune cell estimates were confounded by incomplete 
perfusion of the dural vasculature, as well as to determine the distribution of major immune cell 
populations detected within the dura, Macs, NK, and T-cells were assessed in situ with ED2-, 
CD161a-, and CD3-like immunoreactivity (-LI), respectively.  There was a high density of ED2-
LI cells throughout the dura, both surrounding dural vasculature (Figure 3A, top panel and insert) 
as well as in “extravascular” areas (Figure 3A, bottom panel).  A much lower density of 
CD161a-LI and CD3-LI cells were present surrounding the vasculature (Figure 3B and C, top 
panels and insets) as well as in “extravascular” areas (Figure 3B and C, bottom panels).  
Together, these observations suggest that there is a large and diverse immune cell population in 







Figure 3.  Distribution of immune cells in the naïve male dura.   
Macrophage, NK cell and T cell distributions were examined in situ with immunohistochemistry for ED2- (A), 
CD161a- (B), and CD3- (C) like immunoreactivity (-LI), respectively.  Immune cells were observed in high density 
throughout the dura, both surrounding dural vasculature (top panels and inserts) as well as in “extravascular” areas 
(bottom panels).  Smaller numbers of CD161a-LI and CD3-LI cells were observed. 
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2.3.2 Sex, stress, and sympathetic innervation influence dural immune cell proportions 
2.3.2.1 Immune cells in the dura 
While there was no detectable difference between naïve male (n=7) and female (n=6) rats 
in the proportion of total immune cells (CD45+) in the dura (Figure 4A, “Intact, naïve” groups), 
there was a significant (p<0.05) interaction between sex and stress (“Intact” groups).  This was 
due to a stress-induced increase in dural immune cells present in males, but not females, that was 
significantly greater (p<0.05; n=6) immediately after stress (0 hr) and maintained (p<0.05; n=8) 
for 24 hr after stress. 
There was a significant (p<0.05) interaction between sex and SPGN innervation in naïve 
animals on the proportion of immune cells in the dura (“Intact, naive” and “SPGNx, naive” 
groups).  This was due to the significant (p<0.05) decrease in immune cells with SPGNx in naïve 
females (n=6), and increase with SPGNx in naïve males (n=6).  Folding all additional groups 
into the analysis revealed a significant (p<0.05) interaction between sex, stress, and SPGN 
innervation on dural immune cells.  Importantly, some SPGNx effects were also seen in sham 




Figure 4.  Sex-, stress- and SPGN-dependent changes in the percent of CD45+ immune cells in the 
dura (relative to the total number of live cells recovered). 
Data are presented as a percent of naïve males to facilitate comparisons between groups.  (A) There was a 
significant interaction between sex and stress on the proportion of live immune cells in the dura, p<0.05 (“intact” 
groups).  Also, there was a significant (p<0.05) interaction between sex and SPGN innervation in naïve animals on 
the proportion of immune cells in the dura (“Intact, naive” and “SPGNx, naive” groups).  Lastly, there was an 
interaction between sex, stress, and SPGN innervation (p<0.05) on the proportion of immune cells in the dura.  (B) 
Similar to male SPGNx groups, male sham operated rats also showed the loss of a stress-induced increase in 
immune cells.  Number of animals per group (N) included above x-axis group labels.  (CVS=chronic variable stress; 
SPGNx= surgical removal of sympathetic post ganglionic neurons; H1=a priori hypothesis 1: sex difference in 
“Intact, naïve” groups, analyzed with a t-test; H2=a priori hypothesis 2: sex x stress comparison in “Intact” groups, 
analyzed with a 2-way ANOVA; H3=a priori hypothesis 3: sex x SPGNx in “naïve” groups (ie “Intact” vs “SPGNx” 
naïve), analyzed with a 2-way ANOVA; H4=a priori hypothesis 4: sex x stress x SPGNx interaction between all 
groups, analyzed with a 3-way ANOVA).  * is p < 0.05. 
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2.3.2.2 Myeloid derived dural immune cell subtypes 
Macrophages/monocytes, granulocytes, mast cells: The proportion of Macs was 
significantly (p<0.05) higher in the dura from intact naïve females than intact naïve males 
(Figure 5A).  There was also a significant (p<0.05) interaction between sex and stress on the 
proportion of Macs in the dura.  This was due to a stress-induced increase in Macs present in 
males, but not females, that was significantly greater immediately after stress (p<0.05) and 
maintained with a 24 hr delay after stress (p<0.01), compared to naïves.  Additionally, there was 
a significant (p<0.05) interaction between sex and SPGN innervation in naïve rats on the 
proportion of Macs in the dura.  The increase in Macs in naïve SPGNx males was significant 
(p<0.05), where there was only a trend (p=0.056) toward a decrease in Macs in naïve SPGNx 
females.  Of note, while the trend in the decrease in naïve SPGNx females was observed in the 
sham surgery group, the significant increase Macs in naïve SPGNx males was not (Figure 5B).  
Lastly, there was a significant (p<0.05) interaction between sex, stress, and SPGN innervation on 
Macs in the dura (Figure 5A), although some SPGNx effects were also seen in sham operated 
rats (Figure 5B). 
Dendritic cells: There was a significant (p<0.05) interaction between sex and stress on 
the proportion of dural DC cells (Figure 5C).  This was due to a stress-induced increase in DCs 
present in males, but not females, which was significant (p<0.001) immediately after stress.  
There was also a significantly (p<0.05) higher proportion of DCs in naïve males than females 
following SPGNx.  Lastly, there was a significant (p<0.05) interaction between sex, stress and 
SPGNx on the proportion of dural DCs.  The stress-induced increase in DCs in SPGNx females 
was significant (p<0.001) immediately after stress.  Interestingly, in sham rats the stress induced 




Figure 5.  Sex-, stress- and SPGN-dependent changes in the percent of myeloid derived immune cells 
dissociated from the dura (relative to the total number of live cells from each dura). 
Data are presented as a percent of naïve males for comparison.  (A) The proportion of Macs was significantly 
(p<0.05) higher in the dura from intact naïve females than males. There was a significant (p<0.05) interaction 
between sex and stress on the proportion of Macs in the dura, (“Intact” groups).  There was also a significant 
(p<0.05) interaction between sex and SPGN innervation in naïve rats on the proportion of Macs in the dura (“Intact, 
naive” and “SPGNx, naive” groups).  Lastly, there was an interaction between sex, stress, and SPGN innervation 
(p<0.05).  (B) Similar to male SPGNx groups, male sham operated rats also showed the loss of a stress-induced 
increase in Macs.  (C) There was a significant (p<0.05) interaction between sex and stress on the proportion of dural 
DC cells (“Intact” groups).  Additionally, there was a significant (p<0.05) interaction between sex, stress, and 
SPGNx.  (D) Interestingly, in sham rats the stress induced increase in DCs was only seen with a delay following 
stress.  Groups, group sizes and a priori hypotheses (H1-4) tested were the same as those in Figure 4.  * is p < 0.05 
and ** is p < 0.01. 
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2.3.2.3 Lymphoid derived dural immune cell subtypes 
T-cells: There was a significant (p<0.05) interaction between sex and stress (Figure 6A) 
on the proportion of dural T-cells.  This was due to a stress-induced increase in T cells present in 
females, but not males, that was significantly greater 24 hrs after stress than immediately after 
stress (p<0.05) or naïves (p<0.01).  Additionally, there was a significant main effect (p<0.05) of 
SPGN innervation.  This was due to an increase in the proportion of T cells in the dura from 
SPGNx than intact rats.  Lastly, the sex and stress interaction and SPGN main effect persisted 
with all groups folded into the analysis.  Some SPGNx effects were again seen in sham operated 
rats (Figure 6B).  
NKT cells: The variability was large for the minor subgroup of T cells, NKT cells, likely 
due to the overall low number of NKT cells in the dura.  Nevertheless, there was a significant 
(p<0.05) main effect of sex on the proportion of NKT cells in intact groups (Figure 6C).  This 
was due to a smaller proportion of NKT cells in females than males.  This overall pattern was 
maintained in SPGNx rats and as a result, SPGN innervation had no significant effect on NKT 
cells.  However, some SPGNx effects were also seen in sham operated rats (Figure 6D). 
 Natural killer cells: The variability was considerably larger for NK cells than any other 
immune cell type studied.  Nevertheless, we were still able to detect a significant (p<0.05) sex by 
stress interaction when all groups were folded into the analysis (Figure 6E).  This was due to a 
significant (p<0.001) increase in NK cells immediately after stress in females.  Neither SPGNx, 
nor sham surgery (Figure 6F), appeared to affect NK cells.    
B- cells: The relative proportion of B-cells was significantly (p<0.05) lower in the dura 
from intact naïve females than males (Figure 6G).  This sex difference persisted as a main effect 
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(p<0.05) after folding in stress groups to the analysis.  Additionally, when folding in all groups 
there was a significant (p<0.05) main effect of SPGN innervation.  The decrease in the 
proportion of B-cells across all SPGNx groups was not detected in the sham surgery groups 
(Figure 6H). 
2.3.2.4 “Unidentified” dural immune cell subtypes 
When all groups were folded into the analysis, the proportion of “unidentified” immune 
cells in females was significantly (p<0.05) greater than in males (Figure 7A).  No significant 







Figure 6.  Sex-, stress- and SPGN-dependent changes in the percent of lymphoid derived immune 
cells dissociated from the dura (relative to the total number of live cells from each dura). 
Data are presented as a percent of naïve males for comparison.  (A) There was a significant (p<0.05) interaction 
between sex and stress on the relative proportion of T-cells (“Intact” groups).  Additionally, there was a significant 
main effect (p<0.05) of SPGN innervation in naïve rats.  Lastly, the sex and stress interaction and SPGN main effect 
persisted with all groups folded into the analysis.  (B) Comparable stress-induced changes in T-cells were observed 
in sham surgery groups as in the SPGNx groups.  (C) There was a main effect of sex (p<0.05) on the proportion of 
NKT cells.  (D) Sham operated groups showed a stress effect in males, which may have been masked by SPGNx.  
(E) There was a significant (p<0.05) sex and stress interaction when all groups were folded into the analysis of NK 
cells. (F) Sham surgery did not appear to affect NK cells.  (G) The proportion of B-cells was significantly (p<0.001) 
lower in the dura from intact naïve females than males, and this sex difference persisted as a main effect (p<0.05) 
after folding in stress groups to the analysis (“Intact” groups).  Additionally, when all groups were folded in, there 
was a significant (p<0.05) main effect of SPGN innervation.  (H) Sham surgery did not appear to affect B-cells.  
Groups, group sizes and a priori hypotheses (H1-4) tested were the same as those in Figure 4.  * is p < 0.05 and ** is 





Figure 7.  Sex-, stress- and SPGN-dependent changes in the percent of unidentified immune cells 
dissociated from the dura (relative to the total number of live cells from each dura). 
Data are presented as a percent of naïve males for comparison.  (A) With all groups folded into the analysis, there 
was a main effect of sex (p<0.05) on the proportion of “unidentified” immune cells.  (B) Sham surgery did not 
appear to affect “unidentified” cells.  Groups, group sizes and a priori hypotheses (H1-4) tested were the same as 




The purposes of this study were twofold: 1) to characterize the identity and proportion of 
immune cells present in the dura; and 2) to determine how the proportion of immune cells in the 
dura was influenced by sex, stress and/or SPGN innervation.  Using a combination of flow-
cytometry, immunohistochemistry and FACS of rat dura, we found that ~17% of the total cells in 
the dura were immune cells, composed of at least 6 subtypes: myeloid derived Macs and DCs, 
and lymphoid derived T-, NKT, NK, and B-cells, identified by lineage specific cell surface 
markers, morphology, and histology.  These 6 immune cell types accounted for ~92% of the total 
dural immune cells.  The relative proportion of these immune cell types was influenced sex, 
stress, and SPGN innervation.  There were significantly more myeloid derived Macs and less 
lymphoid derived B-and NKT cells in the dura of females compared to males.  There was a 
significant influence of stress on the proportion of myeloid derived Macs and DCs in males but 
not females: both immune subtypes were increased by stress in males, and this increase was 
maintained for at least 24 hrs following stress for the Macs.  In contrast, lymphoid derived T-
cells were significantly increased in females with a 24 hr delay following stress.   
Previous data indicate that the dura is enriched with resident myeloid derived mast cells 
(Dimlich et al., 1991, Rozniecki et al., 1999, Strassman et al., 2004, Levy et al., 2007) and 
macrophages (McMenamin, 1999, Reuter et al., 2001, McMenamin et al., 2003, Zhang et al., 
2009).  Our observations extend these previous results in three important ways.  First, we 
quantified the relative proportion of resident immune cells in the dura.  Second we described the 
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impact of sex, stress and SPGN innervation on the proportion of these cells.  And third, our 
results clearly indicate that in addition to the classical resident immune cells, a wide array of 
immune cells traditionally described as “recruited” are also present.  Recruitment versus local 
proliferation may be distinguished in future flow cytometry experiments with lineage markers.  
Previously, lymphoid-derived immune cells have only been described in the dura under 
pathological conditions such as meningitis (Rossi et al., 2004, Nakamura et al., 2007, Tokushige 
et al., 2012) or tumors (Fang et al., 2013).  Because we minimized vascular contamination of 
immune cells by removing blood prior to tissue collection and demonstrated the presence of NK 
and T-cells in situ with IHC, our results strongly argue against the possibility that the presence of 
lymphoid derived immune cells in the dura was an artifact.  
The localization of both lymphoid- and myeloid-derived immune cells near vasculature 
and large nerve bundles (not shown) may enable these cells to play a role in initiation, as well as 
resolution of migraine pain.  We suggest that this is true for all the immune cell types detected, 
despite the relatively small numbers in which some types were present.  Indeed, mast cell 
degranulation drives dural afferent activity (Levy et al., 2007), despite the fact that this 
subpopulation of immune cells appears to represent only ~2.4% of immune cells in the dura as 
estimated by the results of our cytological analysis and toluidine blue staining (Fig 5).   
The available evidence suggests that the relative distribution of immune cell types not 
only varies between tissue types, but even within a tissue type.  For example, differences in the 
number and/or proportion of immune cell types in ear, footpad, back skin and tail have been 
described (Tong et al., 2015).  Similarly, there are differences in the proportion of immune cells 
types in the ascending and descending colon (Braak et al., 2012).  Although Macs are 
consistently the most abundant resident immune cell type in peripheral tissue, the relative ratios 
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of T-cells:Macs and Mast cells:Macs appear to be larger in colon (Braak et al., 2012)>skin (Tong 
et al., 2015)>dura (our study).  These differences are likely to reflect the unique environmental 
demands on various tissues, but may also contribute to the differences in the relative contribution 
of immune cells to chronic pain disorders.      
Clearly, dura is not the only tissue in which immune cells have either been implicated in 
pathophysiology or in which immune cells have been shown to be regulated by sex and/or stress.  
For example, irritable bowel syndrome (IBS) and interstitial cystitis are both more prevalent in 
women than in men and the pain of both of these syndromes are exacerbated by stress.  In both 
cases, immune cell activation has been implicated in the stress-induced increase in pain.  
Immediately following stress we detected increases in myeloid derived immune cells (Macs, 
DCs), although the prevailing theory of stress effects on the immune systems is that acute stress 
(minutes) activates the immune system whereas chronic stress (weeks to months) is 
immunosuppressive (Dhabhar, 2009, Hall et al., 2012).  More recent evidence suggests that the 
immune system can be locally depressed in the skin during any length of a stressor and is 
activated following stress cessation (Neeman et al., 2012).  However, due to the relatively tight 
temporal link between stress and other pain disorders, changes in immune cells over time 
following the termination of a stressor, have not been described in detail in these other tissue 
types.   
While performed as a control, the results from the sham surgery groups were interesting 
in several respects.  Our data showed differential immune responses to sham surgery.  There are 
clear examples of a stressor sensitizing or priming the immune system response to a subsequent 
stress (Frank et al., 2012, Weber et al., 2013), and this may explain the enhanced responses in 
most of the immune cell subtypes with sham surgery.  However surgery, as a stressor, is well 
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documented to result in immunosuppression for less than one week (Cristaldi et al., 1997, Leaver 
et al., 2000, Hogan et al., 2011, Marik and Flemmer, 2012).  That any effect would last for 12 
days in the sham groups was unexpected.  Ultimately, the relative impact of SPGN innervation 
on stress-induced changes in dural immune cells was confounded by the influence of surgery, per 
se, as suggested by the results obtained with the sham surgery group.  However, there were still 
cases of marked differences between SPGNx and sham surgery groups, implicating a role of 
SPGN in the regulation of dural immune cells.  This was most clearly evident in the proportion 
of Macs, DCs, and T-cells, which were significantly higher in SPGNx naïve males but not 
females. 
Our observations raise several new areas of investigation concerning the mechanisms 
underlying the impact of sex, stress and SPGN innervation on immune cells in the dura.  Given 
evidence of gonadal hormone regulation of immune cells (Oertelt-Prigione, 2012, Pennell et al., 
2012, Yakimchuk et al., 2013), it will be important to determine the extent to which differential 
regulation of immune cells in the dura is dependent on gonadal hormones.  To begin to address 
this issue, we analyzed uterus weights as an indirect measure of cycling in the rats (Ji et al., 
2008).  Although a subtype of migraine is correlated with the menstrual cycle in humans, we did 
not find correlations between immune cell subtypes and uterus weights of rats, suggesting that 
hormone fluctuations associated with the estrus cycle in female rats was not likely responsible 
for the sex differences described observed in the dura (data not shown).  Additionally, with 
evidence of adrenergic regulation of immune cells as well, it will be important to determine if 
norepinephrine is the mediator primarily responsible for the impact of SPGN innervation on 
immune cells.  However, given our evidence of several immune cell types influenced by stress 
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but not SPGN innervation or in which there was an interaction between stress and SPGN 
innervation, additional mediators are likely to contribute to the regulation of dural immune cells. 
While the full implications of the dynamic regulation of dural immune cells will ultimately 
require functional analysis, the changes observed in this study have at least two important 
implications.  First, the observation that there is a sex difference in the stress-induced increase in 
dural immune cells suggests that it may not only be possible, but necessary to use different 
strategies for the most effective treatment of migraine in men and women.  Second, our 
observations provide the first evidence implicating T-cells in migraine pathogenesis, where the 
changes observed may not only account for the sex difference in the manifestation of migraine, 
but the delay in the initiation of a migraine attack following a period of stress. 
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3.0  SEX-, STRESS-, AND SYMPATHETIC POST-GANGLIONIC NEURON-
DEPENDENT CHANGES IN THE EXPRESSION OF PRO- AND ANTI-
INFLAMMATORY MEDIATORS IN RAT DURAL IMMUNE CELLS 
Migraine attacks are associated with sterile inflammation of the dura.  Immune cells are a 
primary source of inflammatory mediators, and we therefore sought to further explore the link 
between dural immune cells and migraine.  Based on the observations that migraine is more 
common in women than in men, stress is the most common trigger for a migraine attack, and 
sympathetic post-ganglionic innervation of the dura enables local control of dural immune cells, 
we hypothesized that stress shifts the balance of inflammatory mediator expression in dural 
immune cells toward those that trigger a migraine attack, where these changes are larger in 
females and dependent, at least in part, on sympathetic post-ganglionic innervation of the dura.  
Our objective was to test this hypothesis.  Dura were obtained from naïve or stressed, intact or 
surgically sympathectomized, adult male and female rats.  Dura were assessed immediately or 24 
hrs after termination of four continuous days of unpredictable, mild stressors.  Following 
enzymatic digestion of each dura, myeloid and lymphoid derived dural immune cells were 
isolated by fluorescence activated cell sorting for semi-quantitative polymerase chain reaction 
analysis.  In myeloid derived dural immune cells there was an increase in pro-inflammatory 
mediator mRNA following stress, particularly in females, which remained elevated with a 24 hr 
delay after stress.  There was a stress-induced decrease in anti-inflammatory mediator mRNA 
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immediately after stress in females, but not males.  The stress-induced changes were attenuated 
in sympathectomized females.  In lymphoid derived dural immune cells, there was a persistent 
increase in pro-inflammatory mediator mRNA following stress, particularly in females.  A stress-
induced increase in anti-inflammatory mediator mRNA was also observed in both males and 
females, and was further attenuated in sympathectomized females.  Consistent with our 
hypothesis, there is a stress-induced shift in the balance of pro- and anti-inflammatory mediator 
expression in dural immune cells that is more pronounced in females, and is dependent, at least 
in part, on sympathetic post-ganglionic innervation in females.  This shift in the balance of 
inflammatory mediator expression may not only play an important role in triggering migraine 
attacks, but suggests it may be possible, if not necessary to employ different strategies to most 
effectively treat migraine in men and women. 
3.1 INTRODUCTION 
While still an area of active debate, there continues to be compelling evidence in support of 
sterile inflammation of the dura as an underlying mechanism of a migraine attack (Waeber and 
Moskowitz, 2005).  Pro-inflammatory mediators are increased in plasma and cerebrospinal fluid 
during migraine attacks (Sarchielli et al., 2000, Perini et al., 2005, Fidan et al., 2006, Sarchielli et 
al., 2006), and application of these mediators can activate and/or sensitize dural afferents in rats 
(Strassman et al., 1996, Harriott and Gold, 2009, Zhang et al., 2011, Yan et al., 2012).  
Additionally, stimuli such as glyceryl trinitrate, which can evoke a delayed migraine in 
migraineurs but not controls (Thomsen et al., 1994), are associated with an increase in the 
expression and release of pro-inflammatory mediators in the dura (Reuter et al., 2001).  Immune 
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cells are one primary source of pro- and anti-inflammatory mediators in the dura, and in the 
present study we therefore began to explore immune cell regulation of inflammation in the dura 
and thus migraine pain. 
To assess the link between immune cells and migraine, we focused on three clinical 
features of migraine.  The first is the sex difference in the prevalence of migraine, which is 
present in women at a rate roughly three times that seen in men (Pietrobon and Moskowitz, 
2013).  The second is stress.  Over 80% of migraineurs report that their attacks are commonly 
triggered by stress, and 60% report it as their main trigger (Martin, 2010)  Importantly, the 
stress-exacerbation of migraine has a unique temporal pattern, where attacks often occur during 
the relaxation phase after stress (Sauro and Becker, 2009).  The third feature is sympathetic 
dysregulation, where sympathetic hypofunction is often observed in migraineurs (Peroutka, 
2004), and α-adrenergic agonists and β-adrenergic antagonists can decrease the frequency of 
migraine attacks (Goadsby and Sprenger, 2010).  Further evidence suggesting sympathetic post-
ganglionic neurons (SPGNs) may contribute to the link between immune cells and migraine 
includes: 1) the dura is richly innervated by SPGNs (Keller et al., 1989, Harriott and Gold, 
2008), enabling local control of resident immune cells, 2) SPGN fibers are activated by stress, 
and 3) the 5-HT1D receptor, a primary target for triptans, is present on these neurons (Harriott 
and Gold, 2008).  Each of these features may influence immune cells either directly or indirectly 
(Ignatowski et al., 1996, Shakhar et al., 2000, Szelenyi et al., 2000, de Coupade et al., 2004, 
Barker et al., 2005, de Coupade et al., 2007, Leposavic et al., 2008, Pennell et al., 2012, Sanders, 
2012, Yakimchuk et al., 2013). 
Thus, we hypothesized that stress shifts the balance of inflammatory mediator expression 
in dural immune cells toward those that trigger a migraine attack, where these changes are larger 
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in females and dependent, at least in part, on SPGN innervation of the dura.  To begin to test this 
hypothesis, we analyzed the mRNA expression of pro- and anti-inflammatory mediators in 
immune cells in the dura of male and female rats.  The impact of stress was assessed by 
comparing immune cells in naïve rats to those immediately, or with a delay, following the 
termination of chronic stress.  Finally, to determine whether local SPGN signaling may 
contribute to dural immune cell regulation, naïve and stressed rats were studied following SPGN 
denervation of the dura. 
3.2 METHODS 
3.2.1 Animals 
Adult male (200-300g; n=35) and female (150-250g; n=40) Sprague-Dawley rats (Harlan 
Sprague-Dawley, Indianapolis, IN) were used for all experiments.  Animals were housed in the 
University of Pittsburgh Association for the Assessment and Accreditation of Laboratory Animal 
Care approved animal facility two per cage on a 12:12 light:dark cycle with food and water ad 
lib unless indicated.  Procedures were approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee and performed in accordance with National Institutes of Health 
Guide for the Care and Use of Laboratory Animals.   
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3.2.2 Chronic variable stress (CVS) 
Animals were exposed to chronic variable stress (CVS), consisting of an ongoing series of 
“mild” stressors applied for variable durations over a period of 4 days.  The paradigm was 
adapted from unpredictable chronic mild stress models of depression (Grippo et al., 2004), and 
was compressed from 3 weeks to 4 days.  This allowed us to model the length of stressors that 
typically trigger migraines (i.e., stress from a workweek or studying for an exam).  The 
presentation of many different kinds of stressors for different lengths of time over the 4 days 
allowed us to mimic a more complex, non-habituating stress.  Additionally, with stressors 
presented constantly (as opposed to “repeated” chronic stress models where one stressor is 
presented for a short period of time for multiple days), this design allowed us to model the 
constant stress that typically triggers a migraine, as well as create a clear “relaxation period” 
following the stress during which migraines typically occur. 
After arrival, rats were housed in a “home” room for at least 6 days, and subsequently 
subjected to CVS in a separate, isolated housing room.  Rats were single-housed, an average of 2 
stressors were presented at any given time, and each stressor was presented twice over the 4 
days.  The schedule was semi-randomized to ensure that the same stressors were not always 
paired together or back-to-back.  Nine different stressors were used and these included: food 
deprivation (12-16 hrs each), water deprivation (12-16 hrs each), overnight illumination (no 12hr 
dark cycle), cage tilt (18° angle, 8-16 hrs, once on each of the short and long cage axis), paired 
housing with a stranger (8-16 hrs each), damp bedding (12-16 hrs each), white noise (85dB of 
white noise, 3-5 hrs each), strobe light (1 Hz, 4-6 hrs each), and predator odor (two 5cm2 pieces 
of cloth from predator cages were hung in rat cages, 30 min ferret odor once and 1 hr cat odor 
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once).  Rats with a delay period of “relaxation” after CVS were returned to the home housing 
room for that time. 
It is important to note we are not proposing that CVS is a model of migraine, nor do we 
anticipate that this stress paradigm causes migraine in rats.  Rather we have proposed to study 
changes in response to stress because we hypothesize that these changes may contribute to the 
initiation of a migraine attack in migraineurs. 
3.2.3 Bilateral superior cervical ganglion sympathectomy (SPGNx) 
One week prior to any experimentation, a group of animals underwent bilateral surgical removal 
of superior cervical ganglia, the cell bodies giving rise to sympathetic innervation of the dura.  
Animals were deeply anesthetized with an intraperitoneal injection of anesthetic cocktail [55 
mg/kg ketamine (Fort Dodge, Fort Dodge, IA), 5.5 mg/kg xylazine (LLOYD, Shenandoah, IA), 
and 1.1 mg/kg acepromazine (Butler Schein, Dublin, OH)].  Superior cervical ganglia were 
accessed via a midline incision through the skin overlaying the trachea followed by blunt 
dissection of the muscles and connective tissue on either side of the trachea.  Following excision 
of the ganglia and visual confirmation of hemostasis, the incision site was closed.  Prior to 
recovery from anesthesia, rats received an intramuscular injection of buprenorphine (0.03 mg/kg; 
Reckitt Benckiser Pharmaceuticals, Richmond, VA). 
3.2.4 Isolation of dural cells 
Prior to dural tissue collection, animals were deeply anesthetized with an intraperitoneal 
injection pentobarbital (60-70 mg/kg; Vortech Pharmaceuticals, Dearborn, Michigan, USA) 
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followed by a rapid transcardiac perfusion with 60mL cold 1x phosphate-buffered saline (PBS; 
pH 7.2).   
Following careful removal of occipital and parietal bones, dura extending from -4 to 
15mm (caudal to rostral of the convergence of the sinuses) and ±11mm (lateral) was collected 
and placed in 5mL of Dulbecco’s Modified Eagle Medium-F12+ [Advanced DMEM-F12 
(Gibco, Grand Island, NY), to which 10 U/mL each of penicillin and streptomycin (Invitrogen, 
Carlsbad, CA), 5 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Calbiochem, 
San Diego, CA), and 2 mM L-glutamine (Invitrogen), were added] with 0.1% Collagenase P 
(Roche, Indianapolis, IN) in a sealed 60x15mm glass Petri dish and incubated for 1hr at 37°C in 
a shaking water bath.  Dura were then mechanically dissociated in this solution with fire-
polished Pasteur pipettes, centrifuged at 250g, resuspended in 5 mL fresh DMEM-F12+, 
centrifuged again, and resuspended in 1mL staining media [(SM); Ca2+/Mg2+ free Dulbecco’s 
PBS (Lonza, Walkersville, MD), 3% heat inactivated newborn calf serum, 1mM EDTA 
(ethylenediaminetetraacetic acid), 0.02% sodium azide].  The final cell suspension was filtered 
through 50µm mesh (Sefar, Heiden, Switzerland) and subsequently processed.  This protocol 
was adapted from (Borghesi et al., 2005, Steenhuis et al., 2008, Santos et al., 2014).  Cell 
viability was uniformly >80%. 
3.2.5 Fluorescence activated cell sorting (FACS) 
FACS, with the gating strategy illustrated in Figure 8, was used to collect myeloid and lymphoid 
populations of immune cells from each dissociated dura.  Cells were first blocked with 10% rat 
serum for 10min to minimize non-specific binding of antibodies, resuspended in SM, and then 
incubated in primary antibodies for 20min.  They were then washed in SM 3 times prior to a 
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final resuspension in 1µg/mL propidium iodide (PI; Molecular Probes, Eugene, OR) to exclude 
dead cells (viability), and immediately sorted.  Post sort purity was >97%.  Both primary 
antibodies were mouse monoclonal raised against rat epitopes from BD Biosciences (San Diego, 
CA) and were used at the following dilutions: APC cy7 CD45 (clone OX-1) 1:100 and PEcy7 
CD11b/c (clone OX-42) 1:50.  Myeloid cells were defined as CD45+CD11b+CD11c+.  Lymphoid 
cells were defined as CD45+CD11b-CD11c-.  Specificity of the antibodies has been previously 
documented (Ozaki et al., 2012).  Fluorescence minus one antibody controls were used to 
identify negative staining in dural cells(Herzenberg et al., 2006).  FACS was performed on a 3 
laser, 11 detector FACS Aria (BD Biosciences).  Samples were sorted into buffer for qPCR and 
immediately processed.  An average of 132,974 ± 3675 myeloid cells and 45,394 ± 1520 






Figure 8.  Gating strategy example used for the isolation of myeloid and lymphoid immune cell 
subtypes from the dura. 
Data are from a male naïve rat.  The day of the experiment, dural cells were dissociated and stained with antibodies 
specific to markers of immune cells (CD45+) and of myeloid derived immune cells (CD11b/c+).  Non-myeloid 
derived immune cells (CD45+/CD11b/c-) were considered lymphoid derived immune cells.  Viability was uniformly 
80-85%, as determined by PI and trypan blue staining.  Spleen cells were used for compensation controls.  This 
resulted in an average of 132,974 ±3675 (n=75) myeloid cells and 45,394 ±1520 (n=75) lymphoid cells sorted per 
dura.  Image from Diva software. 
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3.2.6 Real time polymerase chain reaction (qPCR) 
RNA extraction was performed according to RNeasy® Micro Kit (Qiagen, Hilden, Germany) 
specifications.  Briefly, cells were sorted directly into 350µL of RLT buffer with 10µL/mL β-
mercaptoethanol.  Samples were homogenized by passing the lysate 6 times through a 1mL 
syringe with a 27G needle followed by 30s of vortexing.  One volume of 70% ethanol was added 
and the sample spun through a column.  The column was washed, treated with DNase 1 for 
15min, washed with buffer followed by 80% ethanol, and RNA eluted from the column in 20µL 
RNase-free water followed by first stand cDNA synthesis by random-hexamer/oligo-d(T)-
primed, Superscript III (Invitrogen)-mediated reverse transcription.  Gene expression of pro- and 
anti-inflammatory mediators was measured by semi-quantitative, real time polymerase chain 
reaction (qPCR) on a CFX Connect real time cycler (Bio-Rad, Hercules, CA, USA).  The targets 
and sequences of the primer pairs are listed in Table 1.  The gene expression of each 
inflammatory molecule was quantified by linear regression of individual amplification curves 
using LinReg PCR (Ruijter et al., 2009), and normalized to the quantity of internal reference 
standard gene transcript Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), β-actin, or β2 
microglobulin (β2M).  Normalization to each internal reference produced very similar results.  
For example, the expression ratio of β-actin to GAPDH in myeloid derived immune cells from 
naïve intact and stressed (0 hr and 24 hr) males were 0.863 ± 0.002, 0.869 ± 0.005 and 0.861 ± 
0.003, respectively, and 0.873 ± 0.003, 0.875 ± 0.004 and 0.873± 0.005, respectively for the 
same groups of females.  Similarly, the expression ratio of β2M to GAPDH was 1.000 ± 0.004, 
1.001 ± 0.004 and 1.001 ± 0.002 in the three groups of intact males and 0.994 ± 0.002, 0.994 ± 
0.004 and 0.989 ± 0.004 in the intact groups of females.  Comparable ratios were observed in the 
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SPGNx groups and for lymphoid derived cells as well.  Because of the small but consistent 
difference between males and females with respect to the relative expression of all internal 
reference targets, we did not assess the presence of sex differences in the expression of 
inflammatory mediators.  Rather, we only assessed the impact of sex on the stress and/or 
SPGNx-induced changes in inflammatory mediator expression.  Data are displayed relative to 
GAPDH.  
The pro- and anti-inflammatory mediators studied were chosen based on established links 
to migraine.  Tumor necrosis factor alpha (TNFα), interleukin 1β (IL-1β), and interleukin 6 (IL-
6) are potent pro-inflammatory mediators increased in the plasma of migraineurs during an 
attack (Perini et al., 2005, Fidan et al., 2006, Sarchielli et al., 2006).  TNFα (Zhang et al., 2011) 
and IL-6 (Yan et al., 2012) have been shown to sensitize dural afferents.  Additional pro-
inflammatory mediators included inducible nitric oxide synthase (iNOS) and cyclooxygenase 1 
and 2 (COX1 and COX2).  Glyceryl trinitrate, a nitric oxide (NO) donor, is a well-described and 
reliable trigger for delayed migraine attacks (Thomsen et al., 1994).  Additionally, NO 
metabolites are increased in the plasma during attacks (Sarchielli et al., 2000, Fidan et al., 2006), 
and there is an increase in NO production in monocytes from the blood of migraine patients 
(Sarchielli et al., 2006).  A marker for NO production, iNOS, was also increased in dural 
macrophages stimulated with nitroglycerin (Reuter et al., 2001).  The pro-inflammatory actions 
of prostaglandins, primary COX metabolites, have been well described and are upregulated in 
the plasma of migraineurs during an attack (Sarchielli et al., 2000).  Non-steroidal anti-
inflammatory drugs, which inhibit the activity of COXs, remain one of the most effective 
abortive treatments for migraine (Jakubowski et al., 2005).   
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The anti-inflammatory mediators studied included: interleukin 10 (IL-10), interleukin 4 
(IL-4), and pro-opiomelanocortin (POMC).  IL-10 and IL-4 are potent anti-inflammatory 
cytokines released from immune cells, and are upregulated in the plasma of migraineurs during 
an attack (Munno et al., 1998, Munno et al., 2001, Perini et al., 2005).  β-endorphin, an 
endogenous opioid, is decreased in the plasma of migraineurs during an attack (Leone et al., 
1992, Misra et al., 2013).  POMC, the precursor peptide for the production of β-endorphin, is 
produced in immune cells and endogenous opioids can be released from immune cells (Rittner et 
al., 2005, Rittner and Stein, 2005).  Lastly, in a transgenic knock-in mouse model of familial 
hemiplegic migraine type 1, the trigeminal ganglia expressed increased numbers of activated 
monocytes and mRNA levels of IL-1β, IL-6, IL-10, and TNFα (Franceschini et al., 2013). 
 
Table 1.  Primer sequences (5’3’) 
 Forward Reverse Accession # Size (bp) 
TNFα AGAAACACACGAGACGCTGA ACTCAGGCATCGACATTCCG NM_012675.3 119 
IL-1β ACAAGGAGAGACAAGCAACGAC TCTTCTTTGGGTATTGTTTGGG NM_031512.2 140 
IL-6 ATCTGCTCTGGTCTTCTGGA TTGCTCTGAATGACTCTGGC NM_012589.2 98 
iNOS GACCAGAAACTGTCTCACCTG CGAACATCGAACGTCTCACA NM_012611.3 137 
COX1 TGACTATCTGACGGGTGACT TTGCTGGACATTGGGTTCTT NM_017043.4 156 
COX2 ATGCTACCATCTGGCTTCGG TGGAACAGTCGCTCGTCATC NM_017232.3 88 
IL-4 CTTACGGCAACAAGGAACAC TTCTTCAAGCACGGAGGTAC NM_201270.1 104 
IL-10 GCATAGAAGCCTACGTGACA TTGGAGAGAGGTACAAACGAG NM_012854.2 151 
POMC GAACGCCATCATCAAGAACG CTCTAAGAGGCTGGAGGTCA NM_139326.2 114 
GAPDH CAGCAACTCCCATTCTTCCA GTGGTCCAGGGTTTCTTACT NM_017008.4 163 
β-actin GCAGGAGTACGATGAGTCCG ACGCAGCTCAGTAACAGTCC NM_031144.3 74 
β2M TTGTGGCTGGAGGTTTAGTC GCTGCCTTTATACCAACCCT NM_012512.2 130 
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3.2.7 Data Analysis 
We tested three related a priori hypotheses based on clinical features of migraine.  The first 
hypothesis was that stress increases the relative expression of pro- vs. anti-inflammatory 
mediators in dural immune cells with a delay following the cessation of stress, based on the 
stress relaxation model of migraine (Sauro and Becker, 2009), and that the stress-induced 
increase is greater in females than males, based on the higher prevalence of migraine in women 
than in men (Pietrobon and Moskowitz, 2013).  Thus, we examined the influence of both sex and 
stress on the expression of pro- and anti-inflammatory mediators in myeloid and lymphoid dural 
immune cells by comparing naïve rats with rats exposed to 4 days of stress (CVS), assessed 
either immediately following stress (CVS+0h) or with a 24 hr delay following stress (CVS+24h).  
The choice of a 24 hr delay was based on results from preliminary experiments also including 6 
and 12 hr delay groups (N=4 each, female).  No significant differences were detected between 
the 6 and 0 hour groups (data not shown).  Larger changes in the expression of both pro- and 
anti-inflammatory mediators were observed with a 24 hr delay compared to 12 hrs (data not 
shown), and thus the 6 and 12 hr delay groups were not pursued further.  The second hypothesis 
was that the relative expression of pro- and anti-inflammatory mediators in dural immune cells is 
dependent on the presence of SPGN innervation, and is more pronounced in females than males, 
based on evidence of both extensive SPGN innervation of the dura (Keller et al., 1989, Harriott 
and Gold, 2008) and adrenergic regulation of immune cells (Ignatowski et al., 1996, Szelenyi et 
al., 2000, Sanders, 2012).  To test this hypothesis, we assessed changes in the expression of pro- 
and anti-inflammatory mediators in dural immune cells from groups of rats surgically 
sympathectomized (SPGNx) by removal of the superior cervical ganglion bilaterally.  Lastly, 
given that stress drives activity in the SPGN, our third a priori hypothesis was that the stress-
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induced increase in the expression of pro- vs. anti-inflammatory mediators in dural immune cells 
in females is dependent on the presence of SPGN innervation. 
The Pfaffl method was used to assess changes in relative expression (Pfaffl, 2001).  
Groups were each set to the respective male or female naïve group as the “control” in the Pfaffl 
calculations to account for the slight sex difference in internal comparators.  To better visualize 
the impact of sex, stress and SPGNx on the pattern of gene expression, data were then 
normalized to the male naïve group for comparison in figures.   
Data were analyzed with 2-way analysis of variance (ANOVA) for sex and stress effects 
(naïve vs. 0, 6, 12 or 24 hrs following CVS), as well as sex and SPGN effects (intact vs. SPGNx) 
in naïve animals, and 3-way ANOVAs for sex, stress, and SPGNs effects with p<0.05 considered 
significant.  The Tukey HSD method was used for post-hoc comparisons if significant 
interactions were detected. 
3.3 RESULTS 
Myeloid and lymphoid derived immune cells interact to mediate the innate and adaptive 
responses of the immune system.  We examined the influence of sex, stress and sympathetic 
innervation on the expression of pro- and anti-inflammatory mediators in these two general 
populations of immune cells in the dura. 
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3.3.1 Myeloid derived dural immune cells: pro-inflammatory mediators  
TNFα:  There was a significant (p<0.05) interaction between sex and stress on the relative 
expression of TNFα in myeloid derived dural immune cells in intact groups (Figure 9A).  A 
significant (p<0.05) stress-induced increase in TNFα was present in females, but not males.  
Post-hoc analysis indicated that the stress-induced increase in TNFα in females was associated 
with a trend towards an increase immediately after stress (p=0.057; n=7) as well as with a 24 hr 
delay following stress (p=0.054; n=6), compared to naïve (n=9).  Also, TNFα in females was 
significantly higher than males (n=6) both immediately following stress (p<0.05) and with a 24 
hr delay (p<0.01).  Folding all additional groups into the analysis revealed a significant (p<0.05) 
interaction between sex, stress, and SPGN innervation on TNFα expression.  Post-hoc analysis 
indicated that there was a loss of the stress-induced increase in TNFα in females with SPGNx in 
addition to the emergence of a stress-induced increase in TNFα in males with SPGNx that was 
significant (p<0.05) immediately after stress (n=5), and persisted for 24 hrs following stress 
(n=6).  
IL-1β:  While there was no significant sex or stress effects in intact animals, there was a 
significant (p<0.05) interaction between sex and SPGN innervation in naïve animals on the 
expression of IL-1β in myeloid derived dural immune cells (Figure 9B).  Post-hoc analysis 
indicated that there was a small but significant (p<0.05) increase in IL-1β with SPGNx in naïve 
males compared to females.  Folding in all additional groups revealed a significant (p<0.05) 
overall interaction between sex and SPGN innervation.  Post-hoc analysis indicated that there 
was significantly (p<0.001) more IL-1β in SPGNx males compared to females, which was not 
present in intact animals.  In females, there also was significantly (p<0.05) less IL-1β in SPGNx 
animals compared to intact. 
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IL-6:  There was a significant (p<0.05) main effect of stress on the relative expression of 
IL-6 in myeloid derived cells in intact groups (Figure 9C).  Post-hoc analysis indicated that the 
increase in IL-6 immediately after stress was significant (p<0.01).  Folding in all groups revealed 
a significant (p<0.05) interaction between sex and SPGN innervation.  Post-hoc analysis 
indicated that the reduced IL-6 in SPGNx females was significant (p<0.05) compared to intact 
females. 
iNOS:  There was a significant (p<0.05) interaction between sex, stress, and SPGNs on 
the relative expression of iNOS in myeloid cells (Figure 9D).  Post-hoc analysis indicated that 
the increase immediately after stress in intact females was significant (p<0.05), but not in 
SPGNx females. 
COX1:  It was only with all groups folded into the analysis that a significant (p<0.05) 
main effect for stress emerged with respect to the expression of COX1 in myeloid cells (Figure 
9E).  Post-hoc analysis indicated that the increase in COX1 with a 24 hr delay after stress, but 
not immediately after stress, was significant (p<0.01).  
COX2:  No significant sex, stress, or SPGN effects were present in COX2 expression in 




Figure 9.  Sex-, stress-, and SPGN- dependent changes in pro-inflammatory mediators in dural 
myeloid cells. 
(A) There was a significant (p<0.05) interaction between sex and stress on the relative expression of TNFα in 
myeloid derived dural immune cells (“Intact” groups).  Folding in all groups revealed a significant (p<0.05) 
interaction between sex, stress, and SPGN innervation on TNFα expression.  (B) There was a significant (p<0.05) 
interaction between sex and SPGN innervation in naïve animals on the expression of IL-1β (“Intact” vs “SPGNx” 
naïve groups).  Folding in all additional groups revealed a significant (p<0.05) overall interaction between sex and 
SPGN innervation.  (C) There was a significant (p<0.05) main effect of stress on the relative expression of IL-6 
(“Intact” groups).  Folding in all groups revealed a significant (p<0.05) interaction between sex and SPGN 
innervation.  (D) There was a significant (p<0.05) interaction between sex, stress, and SPGNs on the relative 
expression of iNOS.  (E) It was only with all groups folded into the analysis that a significant (p<0.05) main effect 
for stress emerged with respect to the expression of COX1.  (F)  No significant effects were present in COX2 
expression.  N: naïve (M=6; F=9), CVS+0h (M=6; F= 7), CVS+24h (M=6; F= 6), SPGNx naïve (M=6; F=6), 
SPGNx CVS+0h (M=5; F=6), SPGNx CVS+24h (M=6; F=6).  (CVS=chronic variable stress; SPGNx= surgical 
removal of sympathetic post ganglionic neurons; H1=a priori hypothesis 1: sex x stress comparison in “Intact” 
groups, analyzed with a 2-way ANOVA; H2=a priori hypothesis 2: sex x SPGNx in “naïve” groups (ie “Intact” vs 
“SPGNx” naïve), analyzed with a 2-way ANOVA; H3=a priori hypothesis 3: sex x stress x SPGNx interaction 
between all groups, analyzed with a 3-way ANOVA)  * is p < 0.05, and ** is p < 0.01. 
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3.3.2 Myeloid derived dural immune cells: anti-inflammatory mediators 
IL-10:  There was a significant (p<0.05) interaction between sex and stress on the relative 
expression of IL-10 in myeloid derived dural immune cells in intact groups (Figure 10A).  Post-
hoc analysis indicated that in females, it was only the stress-induced decrease in IL-10 
immediately after stress that was significant (p<0.01), while in males, it was only the stress-
induced decrease 24 hrs after stress that was significant (p<0.01).  Folding in all additional 
groups revealed a significant (p<0.05) interaction between sex, stress, and SPGNs.  Post-hoc 
analysis indicated that the stress-induced decrease in IL-10 in intact males was not significant 
(p=0.53) in SPGNx males.  
IL-4:  IL-4 expression was below the level of detection in myeloid derived immune cells. 
POMC:  There was a clear sex difference in the expression of POMC, which was below 
the level of detection in myeloid cells harvested from any groups of females (Figure 10B).  With 
all groups folded into the analysis, there was also a significant (p<0.05) interaction between sex 
and stress.  Post-hoc analysis indicated that while small, the stress-induced decrease in males 






Figure 10.  Sex-, stress-, and SPGN- dependent changes in anti-inflammatory mediators in dural 
myeloid cells.   
(A) There was a significant (p<0.05) interaction between sex and stress on relative expression of IL-10 in myeloid 
derived dural immune cells (“Intact” groups).  Folding in all additional groups revealed a significant (p<0.05) 
interaction between sex, stress, and SPGN.  (B) There was a clear sex difference in the expression of POMC, which 
was below the level of detection in myeloid cells harvested from any groups of females.  With all groups folded into 
the analysis, there was also a significant (p<0.05) interaction between sex and stress.  Group sizes and a priori 
hypotheses tested were the same as those in Figure 9.  ** is p < 0.01. 
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3.3.3 Lymphoid derived dural immune cells: pro-inflammatory mediators 
TNFα:  There was a significant (p<0.05) interaction between sex and stress on the relative 
expression of TNFα in lymphoid derived dural immune cells in intact groups (Figure 11A). 
TNFα was significantly higher in females than males immediately following stress (p<0.05).  
Folding all additional groups into the analysis revealed a significant (p<0.05) interaction between 
sex and SPGN innervation.  Post-hoc analysis indicated that while the difference between intact 
females compared to males was significant (p<0.01), TNFα levels in SPGNx females and males 
were comparable.  Also, in males, there was significantly (p<0.05) more TNFα in the SPGNx 
group compared to the intact group. 
IL-1β:  There was a significant (p<0.05) main effect of stress on the relative expression 
of IL-1β in lymphoid derived dural immune cells in intact animals, which persisted when SPGNx 
groups were folded into the analysis (Figure 11B).  Post-hoc analysis indicated that the level of 
IL-1β immediately after stress was significantly greater than that in naïve (p<0.01) and 24 hrs 
after stress (p<0.01). 
IL-6:  Like IL-1β, there was a significant (p<0.05) main effect of stress on the relative 
expression of IL-6 in lymphoid derived dural immune in intact animals, which persisted when 
SPGNx groups were folded into the analysis (Figure 11C).  Post-hoc analysis indicated that both 
the increase in IL-6 immediately after stress (p<0.01) and with a 24 hr delay after stress (p<0.01) 
were significant relative to naïves.  
iNOS:  There was a sex difference in the expression of iNOS, which was below the level 
of detection in lymphoid cells from all female groups (Figure 11D).  Within males, no significant 
influence of stress or SPGNx was detected. 
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COX1:  There was a significant (p<0.05) main effect of stress on the relative expression 
of COX1 in lymphoid cells (Figure 11E).  Post-hoc analysis indicated that the increase of COX1 
immediately following stress was significant (p<0.01).  This stress effect persisted when SPGNx 
groups were folded into the analysis.  A significant (p<0.05) influence of sex also emerged in the 
analysis of all groups.  There was a significantly (p<0.01) higher level of COX1 expression in 
females than males. 
COX2:  There was a significant (p<0.05) main effect of stress on the relative expression 
of COX2 in lymphoid derived dural immune cells in intact animals, and this difference persisted 
when SPGNx groups were folded into the analysis (Figure 11F).  Post-hoc analysis indicated that 









Figure 11.  Sex-, stress-, and SPGN- dependent changes in pro-inflammatory mediators in dural 
lymphoid cells.   
(A) There was a significant (p<0.05) interaction between sex and stress on the relative expression of TNFα in 
lymphoid derived dural immune cells (“Intact” groups).  Folding all additional groups into the analysis revealed a 
significant (p<0.05) interaction between sex and SPGN innervation on TNFα expression.  (B) There was a 
significant (p<0.05) main effect of stress on the relative expression of IL-1β.  (C) There was also a significant 
(p<0.05) main effect of stress on the relative expression of IL-6.  (D) There was sex difference in the expression of 
iNOS, which was below the level of detection in all female groups.  (E) There was a significant (p<0.05) main effect 
of stress on the relative expression of COX1 in lymphoid cells.  A significant (p<0.05) main effect of sex also 
emerged in the analysis of all groups.  (F) There was a significant (p<0.05) main effect of stress on the relative 
expression of COX2.  Group sizes and a priori hypotheses tested were the same as those in Figure 9.  ** is p < 0.01. 
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3.3.4 Lymphoid derived dural immune cells: anti-inflammatory mediators 
IL-10:  In intact animals, there were significant (p<0.05) main effects for sex and stress on the 
relative expression of IL-10 in lymphoid derived dural immune cells (Figure 12A).  There was 
significantly (p<0.05) more IL-10 expression in intact males than females.  Also, the increase in 
IL-10 immediately after stress was significant (p<0.01) compared to naives.  When the SPGNx 
groups were folded into the analysis, the increase in IL-10 with a 24 hr delay after stress was also 
significant (p<0.01).    
IL-4:  In intact animals, there was a significant (p<0.05) main effect of sex on the relative 
expression of IL-4 in lymphoid derived dural immune cells (Figure 12B).  Post-hoc analysis 
indicated a significantly (p<0.05) higher level of IL-4 expression in females than males.  
Additionally, there was a significant (p<0.05) interaction between sex and SPGN innervation in 
naïve animals.  Post-hoc analysis indicated that IL-4 expression in SPGNx females was 
significantly (p<0.01) greater than in intact females, while no difference between SPGNx and 
intact males was detected.  The level of IL-4 in SPGNx females was also significantly (p<0.01) 
larger than in SPGNx males.  Lastly, with all groups folded into the analysis, there was a 
significant (p<0.05) interaction between sex, stress, and SPGN innervation.  However, post-hoc 
analysis indicated that the trend toward a stress-induced increase in IL-4 in intact female animals 
was not significant (p=0.094), nor was the trend towards a stress-induced decrease in SPGNx 
females (p=0.061). 
POMC:  POMC was below the level of detection in lymphoid derived immune cells 




Figure 12.  Sex-, stress-, and SPGN- dependent changes in anti-inflammatory mediators in dural 
lymphoid cells.   
(A) There were significant (p<0.05) main effects for sex and stress on the relative expression of IL-10 in lymphoid 
derived dural immune cells (“Intact” groups).  The significant stress effect persisted when the SPGNx groups were 
folded into the analysis. (B) There was a significant (p<0.05) main effect of sex on the relative expression of IL-4 
(“Intact” groups).  Additionally, there was a significant (p<0.05) interaction between sex and SPGN innervation in 
naïve animals.  Lastly, with all groups folded into the analysis, there was a significant (p<0.05) interaction between 
sex, stress, and SPGN innervation.  Group sizes and a priori hypotheses tested were the same as those in Figure 9.  






The purpose of the present study was to begin to test the hypothesis that migraine attacks are 
due, at least in part, to a stress-induced shift in the balance of pro- and anti-inflammatory 
mediator expression in dural immune cells toward those that activate and sensitize dural 
afferents, where these changes are larger in females and dependent on sympathetic post-
ganglionic innervation of the dura.  We therefore analyzed of the impact of sex, stress and SPGN 
innervation on the expression of pro- and anti-inflammatory mediators in dural immune cells. 
The most robust changes observed in myeloid derived cells (macrophages, granulocytes, and 
dendritic cells) were stress-induced increases in IL-6 in both males and females, and even more 
strikingly, stress-induced increases in TNFα and iNOS that were selectively observed in females. 
Moreover, in females these changes appeared to depend, at least in part, on the presence of 
cephalic SPGN innervation, as the stress-induced increases in TNFα, IL-6 and iNOS in intact 
females were all attenuated in SPGNx females.  Additionally, in females there was a stress-
induced decrease in expression of the anti-inflammatory mediator IL-10, at least acutely, and 
POMC expression was undetectable.  In lymphoid derived dural immune cells (B-, T-, and 
natural killer cells), there were stress-induced increases in IL-1β, IL-6, COX1 and COX2 in both 
males and females, but a stress-induced increase in TNFα that was only present in females.  In 
contrast to the changes observed in myeloid-derived immune cells, only the stress-induced 
increase in TNFα in females appeared to depend on SPGN innervation, as the stress-induced 
increase in TNFα was attenuated in SPGNx rats.  Finally, there were sex, stress and SPGNx 
effects on the expression of IL-10 and IL-4, with stress-induced increases in IL-10 that were 
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greater in males than females and stress-induced increases in IL-4 in females that appeared to be 
dependent on SPGN innervation.  The overall trend of a stress-induced increase in the expression 
of pro-inflammatory mediators and decrease in the expression of anti-inflammatory mediators is 
consistent with a role for dural immune cells in the initiation of a migraine attack.   
These results raise two important implications for the treatment of migraine.  First, 
observations that 1) there is a sex difference in the stress-induced increase in pro-inflammatory, 
and decrease in anti-inflammatory mediators in dural immune cells, 2) differential anti-
inflammatory mediators are engaged between males and females, 3) some mediators such as 
POMC and iNOS are only expressed in males, and 4) SPGN innervation influenced stress-
induced increases in pro-inflammatory mediators in females but not males, suggests that it may 
not only be possible, but necessary to use different strategies for the most effective treatment of 
migraine in men and women.  For example, opioids in immune cells have been shown to regulate 
persistent inflammation and neuropathic pain (Rittner et al., 2005, Rittner and Stein, 2005), and 
while it may be possible to therapeutically access such an opioid-dependent mechanism in males, 
it may not be possible to do so in females.  Interestingly, this sex difference appears to be tissue 
specific given that in contrast to the dura, levels of iNOS and POMC in myeloid derived immune 
cells from the spleen were comparable in males and females (data not shown).  Second, the 
timing of the stress-induced changes in the expression of several mediators including TNFα, IL-
6, and IL-10 appeared to be particularly relevant to migraine attacks in females, given the 
persistence of the upregulation of the pro-inflammatory mediators and the transient decrease in 
the expression of the anti-inflammatory mediator.  Strategies aimed toward downregulating 
TNFα and IL-6, and upregulating IL-10 and POMC signaling may prove to be viable treatment 
options for migraine. 
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Acute stress is classically thought to exacerbate immune responses while chronic stress 
induces immunosuppression (Dhabhar, 2009, Hall et al., 2012).  Yet in other female-prevalent, 
stress-exacerbated inflammatory disorders there has also been clear evidence of an upregulation 
of immune cell cytokine release (Dinan et al., 2006, Dinan et al., 2008, Corcoran et al., 2013, 
Jiang et al., 2013, Logadottir et al., 2014, Schrepf et al., 2014).  However, migraine attacks 
uniquely occur with a delay after stress (Sauro and Becker, 2009), and the temporal dynamics of 
stress-immune interactions with a delay have not been well described in the context of other 
tissues or disorders, nor in the context of migraine.  Due to the potential importance of these 
temporal dynamics and the fact that the timing of changes in gene expression do no always 
correlate with changes in protein levels, it will ultimately be necessary to determine the impact of 
stress on inflammatory mediator protein levels in dural immune cells.   
Interestingly, the stress-induced increases in pro-inflammatory mediators were SPGN-
dependent in females but not males.  We suggest that this difference may be due to the impact of 
gonadal hormones, in particular estrogens, on the regulation of immune cell adrenergic receptors 
(ARs) and consequently adrenergic regulation of immune cell properties.  Both ERα and ERβ 
estrogen receptors have been described in most immune cells (Pennell et al., 2012, Yakimchuk et 
al., 2013).  Estrogens have been shown to influence the expression of both α- and β-AR in 
immune cells (Shakhar et al., 2000, de Coupade et al., 2007, Leposavic et al., 2008).  For 
example, β ARs are increased on neutrophils in females (de Coupade et al., 2004), and β 
blockers increased LPS-induced neutrophil recruitment in females and attenuated recruitment in 
males (Barker et al., 2005).  Thus, the results of these different patterns of regulation are sex 
differences in the adrenergic regulation of chemotaxis and more relevantly, gene expression 
(Ignatowski et al., 1996, Szelenyi et al., 2000, Sanders, 2012). 
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In summary, we have demonstrated a stress-induced increase in the expression of pro-
inflammatory mediators and decrease in the expression of anti-inflammatory mediators in 
females, which is consistent with a role for dural immune cells in the initiation of a migraine 
attack.  Our results suggest specific mediators such as IL-6, TNFa, IL-10 and POMC could be 
viable therapeutic targets, and that it may be necessary to employ different treatment strategies in 
men and women.  Understanding how migraine triggers initiate an inflammatory response in the 
dura will help identify underlying mechanisms of the disorder. 
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4.0  DISCUSSION 
Given evidence that the pain of migraine originates in the peripheral dural afferents, and that 
sterile inflammation contributes to the activation and sensitization of dural afferents, the question 
I wanted to address coming into this field was, how is inflammation in the dura initiated, which 
could then lead to the start of a migraine attack?  The idea was that if we could start to identify 
these mechanisms, we may be able to develop better prophylactic treatments for migraine.  
Immune cells are a well-known primary source of inflammatory mediators and were a likely 
source of the mediators responsible for sterile dural inflammation.  To me, the most logical and 
relevant way to approach this question, was to characterize changes in immune cells in 
association with three, key clinical features of migraine (sex, stress, and SPGNs).  The strategy 
was that any changes in immune cells/mediators occurring in females, with a delay after stress, 
and which were dependent on SPGN innervation, would be targets that could contribute to the 
initiation of a sterile inflammatory response in the dura. 
4.1 IDENTIFICATION AND CHARACTERIZATION OF IMMUNE CELLS IN THE 
DURA 
When I started this dissertation, the current view of the immune competency of the dura was that 
there were mast cells (Theoharides et al., 1995, Rozniecki et al., 1999, Levy et al., 2007) and 
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macrophages (Reuter et al., 2001), although dendritic cells have been identified as well 
(McMenamin et al., 2003).  However, it was not known if other types of immune cells were 
present in this tissue.  I needed to address this issue first, to begin to examine the possibility of 
immune-mediated inflammation in the dura.  In the migraine field, the standard technique for 
identifying immune cells has been immunohistochemistry (IHC).  Due to limitations of IHC in 
terms of the number of markers that can be studied in the same tissue, the limited quantification 
it affords, and the difficulty in performing any secondary analysis on the labeled tissue, I chose 
to pursue flow cytometry and FACS for the analysis of dural immune cells.  While novel to the 
field of migraine, these powerful techniques address many limitations of IHC and maximize the 
amount of data that can be collected from each animal.  This approach allowed me to identify 6 
different phenotypic subtypes of immune cells in the dura simultaneously, accounting for ~92% 
of the immune cells present.  While I complemented initial experiments with IHC, flow 
cytometry therefore eliminated the need to stain 2-3 dura with 6 different antibodies to identify 
each immune cell subtype with IHC, cutting the animals needed for these studies at least in half.  
Additionally, in rat, many of the immune cell antibodies for IHC are not even available and/or do 
not work in the dura, making the IHC approach even more difficult.  Furthermore, because a 
large number of cells are analyzed (I used 200,000 events per dura) one cell at a time, it is easy 
to quantify changes in cell number as well as fluorescence intensity with a very high level of 
precision.  Finally, with the ability to isolate cell types with FACS, it was possible to use 
quantitative PCR to assess changes in expression of 9 different mediators in subpopulations of 
immune cells.  This enabled me to ascribe changes to a cell type with considerably more 
confidence than that afforded by more traditional approaches involving Western blot or PCR 
analysis of whole dura (Reuter et al., 2001). 
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While the numerous advantages of these approaches vastly outweighed any limitations, I 
acknowledge there were trade-offs to take into consideration.  First, due to the need for 
dissociation, flow cytometry and FACS did not allow me to identify changes in the distribution 
patterns of immune cells throughout the dura.  This highlights the need to use multiple 
approaches to complement results.  Second, the impact of a dissociation process, which 
introduces both enzymatic and mechanical stimuli, as well as a time delay between tissue 
collection and analysis, is not fully known.  However, these variables were controlled for as 
much as possible.  I performed initial control experiments to demonstrate that the process of 
mechanical and chemical dissociation, per se, was not activating the immune cells (macrophages 
did not express CD80 or CD86, and after plating, released TNFα in response to LPS stimulation, 
data not shown).  Also, all animals were treated with the same protocol and data were expressed 
as a percent change from naïve.  Third, the dura was dissected from the top of the cortex.  It is 
very likely that pieces of the pia and even some arachnoid were not fully recovered.  This may be 
an issue because there is evidence suggesting that the distribution of immune cells varies among 
the different layers of the meninges.  For example, dendritic cells are located more 
predominantly in the arachnoid and pia while macrophages are located more predominantly in 
the dura (McMenamin et al., 2003), so I may have underestimated the dendritic cell population in 
these experiments.  Lastly, more than ~10,000 sorted cells were required to reliably and 
accurately recover enough RNA for qPCR.  Due to the number of cells present in any given dura, 
I was unable to obtain enough of each subtype of immune cells from a single animal to enable 
expression analysis in each immune cell subtype.  Nevertheless, I was able to characterize 
changes in immune cells more broadly separated by lineage into myeloid and lymphoid derived. 
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4.2 STUDYING SEX DIFFERENCES 
The large sex difference in migraine (3:1 females: males) has been generally disregarded in basic 
science, as most studies have only been conducted in males.  It was important to me that if I was 
going to study a disorder that occurs most often in women, that I should study it in females as 
well as males.  Inflammatory processing in the dura can be very different in females (see 
Introduction).  Only studying males will most certainly not help explain why women are more 
vulnerable to migraine, and may preclude the identification of mechanisms uniquely responsible 
for migraine in women as well.   
While the analysis of sex differences was a central focus of my thesis, aside from an 
indirect measure of estrus cycle afforded by the analysis of uterine weights (which did not 
significantly correlate with results), I did not even begin to analyze the basis for the sex 
differences observed.  The first question to address this basis would be whether the magnitude or 
even presence of sex differences change across the estrous cycle.  Any changes would then be 
used to implicate gonadal hormones on the differences observed.  However I chose not to assess 
the impact of estrus cycle on dural immune cells for multiple reasons.  First, when studying sex 
differences it is important to initially determine if there are sex differences present before 
proceeding with additional experiments to address the basis of the differences observed.  This 
was the purpose of the experiments in this dissertation.  Second, while the timing of the onset of 
migraine with menarch and resolution with menopause (Neri et al., 1993, Brandes, 2006) 
suggests a role for an activational influence of gonadal hormones in migraine, there are pre-
clinical data to suggest that an organizational influence of gonadal hormones is critical for the 
manifestation of a sex difference in SPGN-dependent inflammation (Green et al., 2001, Green 
and Levine, 2005).  Third, using a rat for the determination of an activational influence of 
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hormones is problematic for several reasons.  Rat estrus cycles differ substantially from human 
(Becker et al., 2005).  This raises concerns about how well information from rat cycling could be 
extrapolated to changes that happen in humans.  Fourth, use of daily vaginal smears for staging 
rats in their estrous cycle is problematic in the context of a study on stress.  Stress is known to 
disrupt cycling, performing the smears is a stressor itself, and there is no appropriate control for 
this procedure to apply to males (Greenspan et al., 2007).  The alternative approach of 
gonadectomy with hormone replacement is a potentially viable alternative.  However, removal of 
the gonads results in the loss of more than just estrogens (or testosterone), and as a result, 
negative results will only enable ruling out a necessary role of the hormone manipulated.  
Nevertheless, having observed a clear sex difference in a number of endpoints, it will be 
important to determine the basis for this sex difference in futures studies.  Such a determination 
would require a systematic approach to manipulating gonadal hormones in both males and 
females (Greenspan et al., 2007). 
4.3 USING CHRONIC VARIABLE STRESS AS AN APPROACH TO IDENTIFY 
HOW INFLAMMATION IS INITIATED IN THE DURA 
Three general approaches have been used to study the effects of inflammation in the dura in the 
context of migraine.  The first has been to use exogenous application of inflammatory mediators 
to the dura or dissociated cells (Strassman et al., 1996, Oshinsky and Gomonchareonsiri, 2007, 
Edelmayer et al., 2009, Harriott and Gold, 2009).  This approach has provided compelling 
support for the suggestion that dural inflammation is critically involved in the initiation of a 
migraine attack as well as the development of chronic migraine (Oshinsky and 
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Gomonchareonsiri, 2007), however does not address the origin of the inflammation.  The second 
approach has been to employ a non-physiological stimulus [i.e., compound 48/80 (Levy et al., 
2007)] capable of directly activating immune cells.  While results obtained with this approach 
confirm that activation of immune cells (although not necessarily dural with the systemic 
administration of such compounds) can activate dural afferents, it is still necessary to confirm 
that such activation occurs in the context of migraine.  The third has been to use stimuli that are 
associated with and/or can trigger a migraine attack [i.e., CSD (Karatas et al., 2013), GTN 
(Reuter et al., 2001), and stress (Theoharides et al., 1995)].  This third approach was the most 
appealing to me, particularly when based on a physiological trigger such as stress.  Strikingly, I 
have only been able to find a single study on the effects of stress on inflammation in the dura.  
Theoharides and colleagues reported mast cell degranulation in the dura in response to acute 
restraint stress (Theoharides et al., 1995).   
What was also appealing to me about the study of stress in the context of migraine, was 
that the temporal delay between stress and a migraine attack uniquely differentiates migraine 
from all other pain syndromes and disorders.  However, despite some very well characterized 
models of stress in the literature (Imbe et al., 2006), to maximally exploit the unique temporal 
dynamic of migraine, it became clear to me that I needed to develop my own model of stress, 
which I referred to as chronic variable stress (CVS).  The problem with most established models 
is that they are associated with relatively short exposures to the stressor (i.e., 30 minutes in the 
repeated sound stress model), once a day over several days.  The result is repeated periods of 
stress and relaxation.  The repeated presentation of the stress clearly has a profound effect 
(Strausbaugh et al., 2003), but produced highly variable results for me (data not shown).  
Repeated exposure to short durations of stress is also very different than the time course of stress 
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that is often an effective trigger for a migraine attack in humans.  Ongoing stress over several 
days is often sufficient to precipitate an attack after the stress has resolved.  Furthermore, 
repetition can often result in habituation.  By designing my stress paradigm with many different, 
randomized stressors applied continuously, I was able to model the constant stress that typically 
triggers a migraine, as well as create a clear relaxation period following the stress during which 
migraines often occur.   
While I was able to demonstrate marked changes in body weight in response to CVS 
(data not shown), in addition to the changes in dural immune cells, it will ultimately be necessary 
for me to confirm that the model is both stressful and non-habituating with more traditional 
endpoints such as plasma CORT, ACTH or NE levels.  It was not possible to collect these data 
on the animals in which dural immune cells were studied, because plasma CORT levels rise 
relatively rapidly (minutes) to even handling and movement, and are confounded by anesthetics 
(Vahl et al., 2005).  It will therefore be necessary to collect unanesthetized core blood from 
additional animals to address this issue, as chronic catheterization and habituation to handling for 
blood collection are both potential confounds with the model employed. 
4.4 EXAMINING THE IMPACT OF SPGN INNERVATION 
Lastly, while parasympathetic innervation of the dura has been studied due to its contribution to 
vasodilation and release of pro-inflammatory mediators (Bolay et al., 2002, Yarnitsky et al., 
2003), SPGN innervation and mediators (i.e. NE) have been generally ignored, despite evidence 
of sympathetic dysregulation in migraineurs (Peroutka, 2004), stress (and thus sympathetic 
activation) as a common trigger for migraine, and evidence of SPGN contribution to 
 95 
inflammatory pain in the periphery (Green et al., 1999, Hucho and Levine, 2007).  Only two 
studies have addressed NE signaling in the dura.  Ebersberger and colleagues demonstrated NE-
induced PGE2 release (Ebersberger et al., 2006), and recently Wei and colleagues have shown 
that NE increases dural afferent excitability and fibroblast activity (Wei et al., 2015).   
I chose to study the effects of SPGN innervation with a bilateral surgical removal of the 
superior cervical ganglion (SCG), eliminating all cephalic SPGN innervation (SPGNx).  A 
bilateral SPGNx was conducted because preliminary experiments (data not shown) using a 
unilateral SPGNx and comparing intact vs. SPGNx hemi-dura revealed partial effects on the 
intact hemi-dura compared to fully intact animals.  While the SPGN innervation of the dura from 
each SCG stops at midline, immune cells may move and released mediators can diffuse across 
the midline.  To avoid this problem, bilateral SPGNx were therefore used.  However I observed 
sham surgery effects on immune cell proportions, even though surgeries were performed 12 days 
before experiments were performed, incision sites had completely healed, there were no signs of 
ptosis, and the effects of surgery as a stressor have only been reported to last for up to a couple 
days (Hogan et al., 2011, Marik and Flemmer, 2012).  While surgeries were performed carefully, 
the nearby vagus nerve could have been damaged, resulting in dysregulation of the cardiac 
response to stress.  Ultimately, additionally experiments will need to be performed to determine 
the basis for the sham effects.  First, sham surgeries can be performed at even earlier time points.  
Also, examination of cardiac responses and vagus nerve recordings can be obtained following 
sham surgeries to confirm or reject the hypothesis of vagus damage.  Another approach to 
eliminate SPGN activity could include a systemic guanethidine injection (Chen et al., 2010), 
however this would unnecessarily remove all SPGN innervation in the rats.  Any attempt to 
create a localized pharmacological manipulation has multiple caveats:  1) this would require a 
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craniotomy for cannula, which is extremely invasive and is known to disrupt resident immune 
cells (Levy et al., 2007), 2) the drug may not diffuse throughout the entire dura from the point of 
the cannula, confounding results, 3) depending on the kinetics of the drug, would require many 
infusions to last through a 5 day experimental design, and 4) again depending on the drug, would 
likely only produce a partial block of SPGN activity. 
4.5 FUTURE DIRECTIONS 
Immune cell mediated inflammation is an incredibly complex processes.  We are only just 
scratching the surface with these initial studies, and more questions have been raised than 
answered by this dissertation.  In light of the approaches I used, discussed above, there are 
multiple directions to take this research in the future.  First, in order to probe for multiple pro- 
and anti-inflammatory mediators in immune cells, I assessed changes in mRNA.  Naturally the 
next steps will be to confirm protein changes and release of the targets identified with mRNA.  
Also, determining changes in activation patterns in subtypes of immune cells (i.e., M1 vs M2 in 
macrophages and Th1 vs Th2 in T cells) will give a larger picture of the immune contribution to 
an inflammatory response.  Classically activated M1 macrophages have been implicated in 
initiating and sustaining inflammation in chronic inflammation, while M2 macrophages are 
associated with the resolution of inflammation (Martinez et al., 2009).  This response mirrors the 
Th1-Th2 polarization of T-cells, where Th1 cells secrete pro-inflammatory cytokines and Th2 
cells secrete anti-inflammatory cytokines (Chapman et al., 2008).  
A particularly interesting question about stress in the context of migraine is, what are the 
possible mechanisms for the unique timing of stress-triggered migraines?  This is an important 
 97 
observation that will help discern mechanisms that may be causal to migraine versus general 
stress mechanisms that are unrelated to migraine.  It also creates a unique window for treatment.  
One mechanism that could account for the timing would be if pro- and anti-inflammatory 
pathways activated by stress “turn off” at different rates.  That is, while both pathways may 
balance out during stress, if anti-inflammatory mechanisms resolve more quickly than pro-
inflammatory mechanisms following termination of stress there would be a vulnerable window 
for an inflammatory response in the dura after stress.  Although there were mixed effects on the 
timing of anti-inflammatory mediator expression in immune cells, there were clear examples of 
pro-inflammatory mediator expression (TNFα, IL-6) that were upregulated with stress, and 
remained upregulated with a delay after stress, in females.  An analogous mechanism that may 
account for the delay in the initiation of a migraine attack would be the timing of stress-induced 
changes in receptor density and/or sensitivity, where anti-inflammatory signaling is blunted 
following chronic stress and pro-inflammatory signaling is enhanced.  For example, traditionally 
in both humans and animal models, acute stress causes an increase in immune responses while 
chronic stress suppresses it (decreased trafficking, activity, and production of cytokines that 
translate to decreases in wound healing, responses to vaccines and autoimmune diseases) 
(Padgett and Glaser, 2003).  However in this study and in studies on other stress exacerbated 
pain disorders, an increase in the pro-inflammatory immune response was found following 
chronic stress.  This is thought to be due to GR desensitization, and loss of CORT-mediated anti-
inflammatory signaling.  Future studies should be directed to examining these possible 
mechanisms for the unique timing of stress-triggered migraines. 
To determine how stress was effecting the changes in dural immune cell number and/or 
expression of mediators, additional experiments will need to be conducted that include 
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manipulations at different levels of the stress axes (i.e., adrenalectomy, hypophysectomy) and of 
specific mediators (i.e., CRH antibody, CORT given to naïve animals, AR antagonist/agonists).  
Barker and colleagues have shown that the sexually dimorphic, stress-induced changes in 
neutrophil recruitment are dependent on an intact SA axis, as demonstrated with adrenalectomy 
and AR antagonist/agonists (Barker et al., 2005).  I have provided evidence to suggest that some 
stress-induced effects on dural immune cells were SPGN dependent, but some were SPGN 
independent and would require these additional experiments.   
Additionally, it will be important to distinguish the impact of activity in the SPGN from 
local, activity independent processes.  Levine and colleagues have demonstrated that NE-induced 
release of PGE2 from the SPGN can occur independent of activity (Gonzales et al., 1991, 
Sherbourne et al., 1992).  One approach to address this issue would be to stimulate the SPGNs by 
implanting an electrode in the SCG.  I performed initial experiments of this nature (data not 
shown).  Chronically instrumented animals would be needed, however, to address this issue.       
In future experiments it will also be essential to put these results in the context of a model 
of migraine, such as GTN infusion.  The prediction is that if immune cell mediated inflammation 
is relevant, I should be able to see differences, particularly in the targets I identified in these 
studies, with a delay after GTN infusion.  Furthermore, I should be able to see differences in the 
response to GTN with a delay after stress.  Additionally, demonstrating an impact on dural 
afferent signaling, second-order neurons in the TNC, as well as changes in “migraine behavior”, 
such as periorbital allodynia and photophobia, will support the relevance of my results to a 
physiological, behaviorally meaningful outcome. 
While my data have broad implications for the understanding of migraine, it would be 
significant to confirm that the primary observations made in this rat model are relevant to 
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humans.  Species differences notwithstanding, one of the biggest limitations to the use of the rat 
model is that the rats are not migraineurs.  Thus, it is possible that changes I observed are normal 
physiological responses to stress that are in fact protective against migraine.  This raises the 
question of whether migraineurs are always migraineurs or if anyone can become a migraineur.  
Polymorphisms and genetic models of migraine (familial hemiplegic migraine) (Eising et al., 
2013) support the idea that migraine may be a unique phenomenon for some people.  However, 
evidence that PFO closures can abolish migraines (Ailani, 2014), and PTSD with or without a 
mild TBI (Theeler et al., 2013) can evoke migraines, suggest that migraine may be on a 
continuum for others.  Oshinsky and colleagues have made the first steps to address these 
difficult issues.  First, through identification of a rat with spontaneous periorbital allodynia and 
subsequent breeding, they have developed a genetic model of spontaneous migraine (Oshinsky et 
al., 2012).  Alternatively, they addressed the question, can you make a rat a migraineur if you 
“push” the system hard enough?  They modeled recurrent headache by applying repeated 
infusions of inflammatory soup over the dura through a cannula.  This produced long-lasting 
periorbital allodynia and pronounced responses to GTN (Oshinsky and Gomonchareonsiri, 
2007).  However, an important parallel line of investigation that I (and others) am pursuing will 
be to compare dura tissue from migraineurs and non-migraineurs. 
4.6 SUMMARY AND CONCLUSIONS 
The strategy and tools utilized in this dissertation allowed me to make a number of novel 
observations about dural immune cells.  I was the first to identify the total proportion of immune 
cells in the dura, and also the first to identify T-, B-, NK- and NKT cells in the dura—immune 
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cells other than mast cells and macrophages.  I found significant proportions of these lymphoid 
derived immune cells in the dura—immune cells generally considered a recruited, adaptive 
response—even in naïve animals.  These observations should change the way those working in 
the field will think about the immune competency of the dura.  Additionally, I was able to 
identify different immune cell subtypes (macrophages in males, and T-cells in females), which 
increased with a delay after stress, suggesting for the first time a possible role for T-cells in 
migraine.  I was also able to identify pro- (TNFa and IL-6) and anti- (IL-10 and POMC) 
inflammatory mediators, up- and down-regulated, respectively, with a delay after stress, 
particularly in females, suggesting that a shift in the balance of pro- and anti-inflammatory 
mediators may also contribute to the initiation of a migraine attack.  Minimally, I have been able 
to expand our view of the dura, revealing it to be a much more immune rich and complex tissue 
than previously appreciated.  Most importantly, I believe my results underscore the possibility 
that it may not only be possible, but necessary to differentially treat migraine in men and women. 
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APPENDIX A  
DISTRIBUTION OF ARTEMIN AND GFRΑ3 LABELED NERVE FIBERS IN THE DURA 
MATER OF RAT 
Lisa A. McIlvried, BS; Kathryn Albers, PhD; Michael S. Gold, PhD 
(Headache 2010;50:442-450) 
 
Objective.—We examined the distribution of artemin and its receptor, glial cell line-derived 
neurotrophic factor family receptor α3 (GFRα3), in the dura mater of rats. 
Background.—Artemin, a member of the glial cell line-derived neurotrophic factor 
family, is a vasculature-derived growth factor shown to regulate migration of sympathetic 
neuroblasts and targeting of sympathetic innervation. The artemin receptor,GFRα3, is present in 
both sympathetic efferents and a subpopulation of nociceptive afferents. Recent evidence has 
shown that artemin may contribute to inflammatory hyperalgesia. The extent to which artemin is 
present in the dural vasculature and its relationship to GFRα3 containing fibers have yet to be 
investigated. 
Methods.—We used retrograde labeling, double and triple labeling with 
immunohistochemistry on the dura mater and trigeminal ganglia of female Sprague-Dawley rats. 
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Results.—Artemin-like immunoreactivity (-LI) was detected in the smooth muscle of 
dural vasculature. GFRα3-LI was present in nerve fibers that closely associated with tyrosine 
hydroxylase or calcitonin gene-related peptide (CGRP). CGRP-LI and transient receptor 
potential ion channel 1 (TRPV1)-LI were present in all GFRα3-positive dural afferents, which 
constituted 22% of the total population of dural afferents. 
Conclusions.—These anatomical results support the hypothesis that artemin contributes 
to dural afferent activity, and possibly migraine pain, through modulation of both primary 
afferent and sympathetic systems. 
 
Key words: peptidergic afferent, sympathetic postganglionic neuron, sympathetically 
mediated pain 
 
Abbreviations: Artn artemin, CGRP calcitonin gene-related peptide, DiI 1,1_-
dioctadecyl-3,3,3_,3_-tetramethylindocarbocyanine perchloride, DRG dorsal root ganglia, 
GDNF glial cell line-derived neurotrophic factor, GFRα3 GDNF family receptor a3, -LI -like 
immunoreactivity, MMA middle meningeal artery, SMA smooth muscle actin, SPGN 
sympathetic postganglionic neuron, TG trigeminal ganglia, TH tyrosine hydroxylase, TRPV1 
transient receptor potential ion channel 1 
 
From Center for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA (L.A. 
McIlvried, K. Albers, and M.S. Gold); The Pittsburgh Center for Pain Research, University of 
Pittsburgh, Pittsburgh, PA, USA (L.A. McIlvried, K. Albers, and M.S. Gold); Department of 
Neurobiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA,USA (K. Albers and 
 103 
M.S. Gold);Department of Medicine, Division of Gastroenterology, University of Pittsburgh, 
Pittsburgh, PA, USA (K. Albers); Department of Anesthesiology, School of Medicine, 
University of Pittsburgh, Pittsburgh, PA, USA (M.S. Gold). 
Address all correspondence to M.S. Gold, E1440 Biomedical Science Tower, 200 
Lothrop St., Pittsburgh, PA 15213, USA. 
Accepted for publication September 1, 2009. 
 
Conflict of Interest: None 
ISSN 0017-8748 
doi: 10.1111/j.1526-4610.2009.01548.x 
Published by Wiley Periodicals, Inc. 
Headache 
© 2009 the Authors 
Journal compilation © 2009 American Headache Society 
A.1 INTRODUCTION 
Artemin (Artn) is a member of the glial cell line derived neurotrophic factor (GDNF) family of 
proteins that signals through the receptor complex of ret and its specific GDNF family receptor 
(GFR)α3.1 Artn is derived from vascular smooth muscle cells and regulates the development of 
sympathetic postganglionic neurons (SPGN), in particular SPGN innervations of the 
vasculature.2 Recent evidence suggests that both Artn and GFRα3 expression persists into 
adulthood in vascular smooth muscle and SPGNs,3 respectively.  
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The GFRα3 is also expressed in a subset of primary afferent neurons that appear to 
function as nociceptors and contribute to inflammatory hyperalgesia. GFRα3-labeled neurons in 
the dorsal root ganglion (DRG) and trigeminal ganglion (TG) have a small to medium-cell body 
size, and express the proinflammatory neuropeptide calcitonin gene-related peptide (CGRP) and 
the transient receptor potential ion channel 1 (TRPV1).4 TRPV1 is activated by heat, protons, 
and endogenous lipid metabolites, and is critical for the manifestation of inflammatory thermal 
hyperalgesia.5 Artn application significantly potentiates TRPV1 signaling in small diameter 
DRG neurons.6 Additionally, peripheral inflammation is associated with an increase in Artn 
expression and injection of Artn causes thermal hyperalgesia.6,7  
Vasodilation of the meningeal vessels is due in part to CGRP release and is considered an 
important component of the neurogenic inflammation thought to underlie migraine. Vasodilation, 
plasma extravasation, and mast cell degranulation contribute to the release of proinflammatory 
substances into the meninges, which can activate meningeal primary afferents ultimately 
resulting in migraine pain.8 The role of vasodilation in migraine is supported by observations that 
headaches can be induced by vasodilatory, nitric oxide-generating agents such as nitroglycerin,9 
and relieved with vasoconstricting agents such as ergots.10 Artn expression in vasculature and its 
influence on sensory nociception and sympathetic development led us to hypothesize that Artn 
may be contributing to migraine pain through both primary afferent and sympathetic systems. 
The goal of this study was to determine if the underlying anatomy supports this hypothesis. 
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A.2 METHODS 
Animals.—Female adult Sprague-Dawley rats (150-250 g, aged 8-12 weeks; Harlan, 
Indianapolis, IN, USA) were used for all experiments. Procedures were approved by the 
Institutional Animal Care and Use Committee at the University of Pittsburgh, and performed in 
accordance with National Institutes of Health guidelines for the use of laboratory animals. 
Tissue Preparation.—Animals were deeply anesthetized with an intraperitoneal 
injection of anesthetic cocktail (55 mg/kg ketamine, 5.5 mg/kg xylazine, and 1.1 mg/kg 
acepromazine), and transcardially perfused with cold 1x phosphate-buffered saline (PBS; pH 
7.2) followed by cold 4% paraformaldehyde. TG, superior cervical ganglia (SCG), and dura were 
collected and postfixed in 4% paraformaldehyde for 1 hour. Dural membranes were processed 
for immunohistochemistry as free-floating whole-mounts, while TG and SCG were equilibrated 
in 30% sucrose, frozen in OCT (Tissue Tek, Torrance, CA, USA), sectioned at 16 mm and thaw-
mounted on SuperFrost plus slides (Fisher Scientific). One dura was embedded in paraffin and 
30 mm cross sections collected and processed for immunohistochemistry. Slides were heated to 
50°C on a hotplate, soaked in CitriSolv (Fisher Scientific) for 10 minutes and rehydrated through 
a series of decreasing ethanol concentrations. Antigen retrieval was obtained by boiling slides for 
10 minutes in 0.01 M sodium citrate, 0.05%Tween 20,pH 6.0. After cooling, slides were washed 
in PBS and processed for immunohistochemistry. 
Immunolabeling.—Dura whole-mounts were placed in blocking solution (10% normal 
donkey serum and 0.3% Triton X-100 in PBS) for 30 minutes and incubated in primary 
antibodies in blocking solution for 2 days at 4°C. TG sections on slides were blocked in 10% 
normal donkey serum and 0.03% Triton X-100 in PBS, and incubated in primary antibodies 
overnight at room temperature. The following antibodies were used: goat anti-GFRα3 (R&D 
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Systems; 1:500), goat anti-mouse Artn (R&D Systems; 1:40), rabbit anti-CGRP (Sigma; 1:500) 
and rabbit anti-tyrosine hydroxylase (Chemicon; 1:500), and rabbit anti-TRPV1 (Alomone Labs: 
1:1000). The specificity of the Artn and GFRα3 antibodies has been previously documented 
(manufacturer’s information11,12). Antibodies were visualized with donkey anti-goat and donkey 
anti-rabbit secondary antibodies conjugated to cyanine 2 or 3 (Jackson ImmunoResearch, West 
Grove, PA, USA) in blocking solution at 1:500 for 2 hours. Dura were mounted on glass plus 
slides and coverslipped using Fluoromount-G (Southern Biotech). Slides were photographed 
under epifluorescence with a Leica DM4000B upright or confocal microscope (Leica, Wetzlar, 
Germany). Images were captured using a Leica DFC300FX camera and processed for brightness 
and contrast with Adobe Photoshop (Adobe Systems, San Jose, CA). 
Retrograde Labeling.—TG and SCG neurons innervating the dura were retrogradely 
labeled as described previously.13 Briefly, a 3 x 3 mm craniotomy was made over the superior 
sagittal sinus, leaving the dura intact. A single drop of 1,1′-dioctadecyl-3,3,3′, 3′-
tetramethylindocarbocyanine perchloride (DiI; 170 mg/mL in dimethylsulphoxide diluted 1:10 in 
saline), or true blue chloride powder (Invitrogen; 1 mg) was applied to the exposed dura. The 
area was covered by dental dam and an acrylic cap. Postoperatively, animals received 
intramuscular injections of penicillin G (100,000 U/kg) and buprenorphine (0.03 mg/kg). 
Animals were sacrificed and ganglia extracted for immunohistochemistry 10-14 days following 
labeling. 
Data Analysis.—Staining was considered positive when the immunofluorescence was 
clearly greater than the signal obtained with no primary antibody. Omission of primary antibody 
was used as a control for non-specific binding of the secondary antibody. The percentage of 
GFRα3-positive dural afferents was determined by ~50 DiI-labeled neurons in each of 4 rats (8 
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total ganglia) that exhibited GFRα3- labeling, and ~100 true blue-labeled neurons in each of 3 
rats (6 ganglia). 
A.3 RESULTS 
Artn is Located in Smooth Muscle Cells of Dural Blood Vessels.—Co-localization of Artn-
like immunoreactivity (-LI) and smooth muscle actin (SMA), a marker for smooth muscle cells, 
was assessed using double-label immunohistochemistry on paraffin embedded cross sections of 
the dura. Artn-LI was evident surrounding blood vessels and co-localized with SMA (Fig. 1). 
These results indicate that Artn is expressed in smooth muscle cells of the dural vasculature. 
GFRα3-LI is Present in Neuronal Fibers of the Dura Mater.—The distribution of 
GFRα3 throughout the dura mater was also assessed in a whole-mount preparation using 
immunohistochemistry. GFRα3-LI was present in a network of nerve fibers, in large bundles of 
axons as well as fine fibers (Fig. 2). Many of these fibers followed the vasculature, with the 
greatest density concentrated around the middle meningeal artery (MMA). Many fibers also 
followed the superior and transverse sinuses (not shown). However, some fibers did not follow 
the vasculature or sinuses, and were observed running perpendicular to the MMA (Fig. 2) and 
other vessels. GFRα3-LI was not detected in mast cells or the vasculature. 
GFRα3-LI is Present in Sympathetic Postganglionic Efferents.—Given the 
developmental link between Artn and sympathetic innervation of the vasculature2 as well as 
evidence of GFRα3 expression in adult SCG3 we sought to determine whether dural fibers with 
GFRα3-LI were SPGNs. Although a small subpopulation of TG neurons also display tyrosine 
hydroxylase reactivity (TH)-LI, dural afferents do not.13 Therefore, TH was used as a marker for 
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SPGN fibers in the dura. TH-LI was present in an extensive network of fibers throughout the 
dura mater, which closely followed the vasculature (Fig. 2A). Close association of GFRα3-LI 
and TH-LI in fibers throughout the dura was extensive. Interestingly, while most double-labeled 
fibers closely followed the dural vasculature, some did not. 
GFRα3-LI, TRPV1-LI, and CGRP-LI are Present in Peptidergic Neuronal 
Afferents.—As mentioned above, GFRα3 is present in a subpopulation of peptidergic DRG 
neurons. To determine whether the same is true in the trigeminal system, we first assessed 
whether the receptor was co-localized with CGRP in the dura. Of note, while CGRP is also 
present in a subset of SPGNs in some species, it is not detectable in the SCG of rat.13 As 
illustrated in Figure 2B, the close association of GFRα3-LI and CGRP-LI was evident in a 
subpopulation of fibers. To confirm that at least some of the GFRα3-LI dural fibers were sensory 
afferents, TG neurons innervating the dura mater were back-labeled with DiI or true blue, and 
subsequently probed for the presence of GFRα3-LI. Approximately 50 DiI-labeled neurons from 
each of 4 rats and 100 true blue-labeled neurons from each of 3 rats were assessed. To avoid 
double-counting, we only counted cells in non-adjacent sections when a nucleus was present. 
While it is possible that true blue and DiI labeled different subpopulations of dural afferents, 
there was no statistically significant difference (P = .10) in the proportion of dural afferents with 
GFRα3-LI labeled with each tracer – 25.9 ±3.9% (mean ± SEM) vs 17.7 ± 1.4% for DiI and true 
blue, respectively. Therefore, data obtained with the 2 tracers were pooled as 22.4 ± 3.0% of 
dural afferents with GFRα3-LI. The TRPV1-LI (Fig. 3) and CGRP-LI (Fig. 4) were seen in 43.2 
± 1.7% and 66.0 ±6.0% of dural afferents, respectively. Twenty-six percent (25.5 ± 2.7%) of 
dural afferents that were labeled with TRPV1 did not show GFRα3-LI, and 47.6 ±3.6% labeled 
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with CGRP did not show GFRα3-LI. All GFRα3-LI dural afferents were TRPV1- and CGRP 
positive. These data are summarized in charts shown in Figure 5. 
A.4 DISCUSSION 
The main findings of this study are: (1) Artn-LI was detected in the smooth muscle of adult rat 
dura mater vasculature; (2) expression of the Artn receptor GFRα3 was detected in afferents that 
innervate the dura; (3) there was extensive close association of GFRα3-LI and TH-LI in dural 
fibers; (4) GFRα3 was present in a minority of dural afferents, but all of these afferents were 
both TRPV1- and CGRP-positive.  
While this is the first demonstration of Artn in the dural vasculature, this observation is 
consistent with other studies reporting Artn expression in vascular structures. For example, 
Damon et al demonstrated the presence of Artn mRNA and protein in carotid, femoral, and tail 
arteries of neonatal and adult rats, as well as in cultured vascular smooth muscle cells. In 
neonatal lacZ Artn+/- mice, Honma et al also found lacZ-LI co-localization with SMA-LI in the 
superior mesenteric artery. This evidence, in combination with previous data supporting the 
specificity of the antibody used,11 supports our conclusion that Artn-LI co-localization with 
SMA-LI in the dural vasculature reflects Artn expression in the smooth muscle.  
We suggest that the majority of GFRα3 expression in the dura is present in fibers of 
SPGNs. This is supported by the comparable labeling patterns of GFRα3-LI and TH-LI in dural 
fibers (Fig. 2A), and the absence of TH staining in dural afferents.13 Additional evidence comes 
from data linking Artn/GFRα3 signaling to proper SPGN innervation of the vasculature during 
development,2 and that the receptor is expressed in the SCG in adults.3 Furthermore, the more 
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limited overlap of GFRα3-LI and CGRP-LI in dural fibers (Fig. 2B,C), in combination with the 
observation that only 28% of dural afferents with CGRP-LI were double labeled with GFRα3 
(Figs. 4 and 5), is also consistent with the suggestion that a minority of GFRα3-LI in the dura 
was associated with dural afferents. However, because it was not possible to assess GRFα3 
levels in SCG, and therefore quantify the extent of co-localization of this receptor in dural 
efferents, and because staining patterns at the cell body may not be the same as those in the 
periphery, conclusions about the extent of co-localization in dural fibers are made cautiously.  
Interestingly, while only present in a minority of dural afferents, the subpopulation of 
GFRα3- containing afferents may play a particularly important role in nociceptive processing in 
the dura. Artn potentiates TRPV1 signaling in DRG neurons, a change that appears to contribute 
to thermal hyperalgesia associated with inflammation of the hindpaw.6,11 Furthermore, activation 
of TRPV1, a calcium permeable ion channel, has been shown to promote the release of CGRP 
from a number of tissues14-16 and contribute to vasodilatation, neurogenic inflammation, and 
mast cell activation.17,18 Our anatomical results raise the possibility that similar processes occur 
in the dura mater, underscored by observations that GFRα3 appears to be present in similar 
subpopulations of nociceptive afferents in the TG and DRG.4  
The anatomical results of the present study suggest a model in which Artn contributes to 
migraine pain indirectly, via the SPGN as well as directly via the sensitization and/or activation 
of dural afferents. In such a model, triggers for migraine such as stress, exercise, and nitric oxide 
which are associated with alterations in cerebrovascular tone would result in the release of Artn 
from vascular smooth muscle. The release of Artn secondary to the modulation of vascular tone 
would account for the mounting evidence against the vascular hypothesis of migraine that is 
based on a direct link between the cerebrovasculature and migraine pain. While the impact of 
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Artn on SPGN properties in the adult has yet to be described, the results of the present study 
highlight the proximity of ligand and receptor. Importantly, there is increasing evidence 
implicating a critical role for the SPGN in neurogenic inflammation and inflammatory 
hyperalgesia.19,20 Additional evidence in support of a link between the SPGN and migraine 
comes from the recent observations that (1) norepinephrine, a neurotransmitter released by 
sympathetic efferents, increases basal levels of prostaglandin E2 from a rat dural preparation;21 
(2) the serotonin 1D receptor, a primary target for the antimigraine triptans, is present in a 
subpopulation of SPGNs.13 Evidence in support of the link between Artn/GFRα3 signaling in the 
primary afferent and migraine pain comes from our evidence of the co-localization of GRFa3 
with TRPV1 and CGRP in combination with evidence for (1) Artn-induced sensitization of 
TRPV1;6,22 (2) TRPV1-mediated release of CGRP (discussed above); (3) a critical role for CGRP 
in migraine pain;23-25 (4) the role for dural afferents in migraine pain.26While further studies are 
needed to confirm the details of this model, it does raise the intriguing possibility that 
Artn/GFRα3 signaling may serve as a novel target for the treatment of migraine. 
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Appendix A Figure 1. 
(A) A cross section of the rat dura mater was immunolabeled for artemin (Artn, left panel) and smooth muscle actin 
(SMA, middle panel).  The merged image (right panel) illustrates co-localization.  (B) Controls in which the primary 




Appendix A Figure 2.   
Double-label immunohistochemistry of whole-mount, adult rat dura mater with anti-glial cell line-derived 
neurotrophic factor family receptor α3 (GFRα3) and (A) anti-tyrosine hydroxylase (TH) or (B,C) anti-calcitonin 
gene-related peptide (CGRP), showed GFRα3-like immunoreactivity (-LI) in sympathetic efferents and peptidergic 
sensory afferents, respectively. (C) Enlarged portion of boxed area in B showing GFRα3-LI fibers that do not show 




Appendix A Figure 3.   
Glial cell line-derived neurotrophic factor family receptor α3 (GFRα3)-like immunoreactivity (-LI) and transient 
receptor potential ion channel 1 (TRPV1)-LI were seen in 17.7 ± 1.4% and 43.2 ±1.7%, respectively, of dural true 
blue back-labeled neurons in adult rat trigeminal ganglia (TG). All GFRα3-LI neurons were also TRPV1-LI. 
Example of dural afferent that was (A) positively labeled for both GFRα3 and TRPV1 (arrow), labeled for only 
TRPV1 (arrowhead), and (B) negatively labeled (arrows). (C) Controls in which the primary antibody was omitted 
show lack of reactivity. Scale bar, 100 µm. 
 
 
Appendix A Figure 4.   
Glial cell line-derived neurotrophic factor family receptor α3 (GFRα3)-like immunoreactivity (-LI) and calcitonin 
generelated peptide (CGRP)-LI were seen in 18.6 ± 2.6% and 66.0 ± 6.0%, respectively, of dural true blue back-
labeled neurons in adult rat trigeminal ganglia (TG). All GFRα3-LI neurons were also CGRP-LI. Example of dural 
afferents that were (A) positively labeled for both GFRα3 and CGRP (arrows), negatively labeled (arrowhead) and 




Appendix A Figure 5. 
Summary of glial cell line-derived neurotrophic factor family receptor α3 (GFRα3), transient receptor potential ion 
channel 1 (TRPV1), and calcitonin gene-related peptide (CGRP) in dural afferents. (A) TRPV1-like 
immunoreactivity (-LI) was seen in 43.2 ± 1.7% of dural afferents, and 17.7 ± 1.4% were labeled for both TRPV1 
and GFRα3. (B) CGRP-LI was seen in 66.0 ± 6.0% of dural afferents, and 18.6 ± 2.6% were labeled for both CGRP 
and GFRα3. All GFRα3-positive dural afferents were CGRP- and TRPV1-positive. 
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APPENDIX B 
INCREASED SYMPATHETIC INNERVATION IN A MOUSE MODEL OF FAMILIAL 
HEMIPLEGIC MIGRAINE 
L.A. McIlvried1, J.S. Mogil2, M.D. Ferrari3, A.M.J.M van den Maagdenberg3,4 and M.S. Gold1  
1Depts of Anesthesiology and Neurobiology, Center for Neuroscience at the University of 
Pittsburgh and Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, USA;   
2Dept of Psychology and Alan Edwards Centre for Research on Pain, McGill Univ., Montreal, 
QC, Canada;  3Department of Neurology, Leiden University Medical Center, Leiden, the 
Netherlands; 4Department of Human Genetics, Leiden University Medical Center, Leiden, the 
Netherlands 
 
Introduction—Mechanisms underlying migraine pain have yet to be fully elucidated.  Stress is 
the most commonly reported trigger for migraine and involves activation of the sympathetic 
nervous system.  More specifically, alterations have been observed in sympathetic post-
ganglionic neuron (SPGN) activity and excitability of nociceptive afferents in the dura mater 
have been implicated in the pathophysiology of migraine. Therefore, we have begun to test 
whether alterations are present in the sympathetic innervation of the dura of transgenic knock-in 
mice that harbor an R192Q missense mutation (i.e. R192Q KI mice) in the α1 subunit of 
voltage-gated Ca2+ channels. In patients, this mutation causes familial hemiplegic migraine 
(FHM) type 1, a monogenic type of migraine with aura associated with long-lasting hemiparesis.  
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Methods—Afferent and sympathetic efferent innervation of the dura from male and 
female R192Q KI and wild-type mice was assessed with Western blotting and 
immunohistochemistry.  
Results—The R192Q mutation had no significant influence on total dural tyrosine 
hydroxylase-like immunoreactive (TH-LI) protein, a marker of sympathetic innervation. 
However, the mutation was associated with significantly more TH-LI vasculature-independent 
fibers innervating the dura (p<0.01), particularly proximal to the transverse sinus.  There was 
also significantly more total TH-LI protein in female mutant non-migraine associated tissue 
(ear), than that in wild-type females or mutant males.  
Conclusions—Hyper-sympathetic innervation, particularly of the dura, was observed in a 
genetic model of migraine.  This may provide an anatomical substrate for the link between stress 





Appendix B Figure 1.  Increased TH-LI vasculature-independent fibers in dura of R192Q mutant 
mice. 
Whole mounts of adult (A) wild-type (WT) female and (B) R192Q mutant male and (C) female mouse dura mater 
were probed with anti-CGRP (green) or anti-TH (red) antibodies. (D) Quantification of TH-LI fibers showed a main 
effect of genotype. Significantly more vasculature-independent fibers were seen in R192Q mice than WT (p<0.005).  
Specifically, more fibers were found in female R192Q mice than WT (p<0.05).  Quantification was performed by 
counting TH-LI fibers that passed through an area parallel but 2mm lateral to the sagittal sinus (D, right).  Density of 
TH-LI vasculature independent fibers in R102Q mutant mice was greatest proximal to the transverse sinus.  N=6-8 




Appendix B Figure 2.  Increased TH-LI innervation in female R192Q mutant mice ear tissue.   
Top: Western blots of adult female and male, wild-type (WT) and R192Q mutant mouse dura (A) and ear (B) tissue 
probed for TH, a marker of sympathetic innervation, and PGP9.5, a marker of total innervation.  Bottom: (A) 
Quantification of western blots of dural tissue showed no significant effects of genotype or sex (p>0.05).  (Female 
WT, n=6; other groups n=7.)  (B) Western blots of a non-migraine associated tissue, ear, showed significantly more 
TH in female mutant mice than males (p<0.05) or WT females (p<0.01).  (All groups n=7.) 
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APPENDIX C 
STRESS INDUCED MAST CELL DEGRANULATION AND PLASMA EXTRAVASATION 
IN THE DURA MATER OF RATS IS REGULATED BY SYMPATHETIC 
POSTGANGLIONIC NEURONS 
L.A. McIlvried1 and M.S. Gold1,2   
1 Center for Neuroscience at the University of Pittsburgh and Pittsburgh Center for Pain 
Research, 2Depts of Anesthesiology and Neurobiology, University of Pittsburgh, Pittsburgh, USA 
 
Introduction—Migraine is a debilitating disorder characterized by long lasting attacks of severe 
head pain, with a high prevalence in females (3:1).  Evidence suggests that inflammatory 
mediators from the dural vasculature and/or dural mast cells contribute to the activation of dural 
afferents during a migraine. Evidence also suggests that migraine attacks are triggered and that 
stress is the most commonly reported trigger for migraine.  The aim of this investigation was to 
determine whether there is a link between stress and changes in dural mast cells and plasma 
extravasation (PE). 
Methods— Adult male and female Sprague Dawley rats were used in all experiments.  
Rats were stressed with a nonhabituating sound stress paradigm consisting of exposures to 5-10 
second 11-19 kHz tones at 105 dB, played randomly once per minute for 30 minutes. Rats were 
exposed to the sound stress on days 1, 3 and 4 to create a non-habituating stress (Strausbaugh et 
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al., 2003).  Groups consisted of “naïve”, “Day 1-1hr” (immediately after the first day of stress), 
“Day 4-1hr” (immediately after the last day of stress), and “Day 5- 24hrs” (24 hr delay after the 
last day of stress).  Furthermore, to determine whether sympathetic postganglionic neurons 
(SPGN) in the dura contribute to the link between stress and changes in the dura, additional 
groups were studied in which superior cervical ganglia were surgically removed (SPGNx) prior 
to any experimental manipulation.  Mast cells were visualized in fixed tissue stained with 
toluidine blue. PE was quantified with a ten minute exposure to Evans blue (50mg/kg IV), 
subsequent extraction from tissue in DMSO and assessment by spectrophotometry at 620 nm.  
Analysis was performed as 2 or 3-way ANOVAs, as appropriate. 
Results— Mast cell degranulation was significantly increased immediately following 
stress, with sex-dependent regulation by SPGNs.  There was no change in the density of dural 
mast cells.  PE in the dura, ear, and viscera was significantly increased immediately following 
stress in both males and females, which recovered by 24hrs.  These effects were SPGN 
dependent. 
Conclusions— There is a complex interaction between the influences of sex, stress and 
sympathetic innervation on the regulation of mast cell degranulation and plasma extravasation in 
the dura.  SPGNs differentially stabilize dural mast cells in males and females during repeated 
non-habituating stress.  An impaired sympathetic system, as observed in migraineurs, could 
result in dysregulation of dural mast cells and a lower threshold for degranulation following a 
stressful trigger, providing a mechanism for subsequent sensitization of dural afferents.  
However, an increase in neither mast cell degranulation nor plasma extravasation per se, can 




Appendix C Figure 1.  Stress-induced, sex-dependent changes in dural mast cell degranulation are 
regulated by SPGNs.   
There was no significant effect of sex on mast cell degranulation in intact rats. However, there was a significant 
effect of sound stress on mast cell degranulation, due to the stress-induced changes in degranulation in males. There 
was a significant effect of SPGNx on mast cell degranulation due to increases in degranulation associated with stress 
in both males and females. Finally, there was a significant interaction between sex, stress and SPGNx due to the 
differential pattern of degranulation observed in response to stress in intact and SPGNx rats.  Numbers in 
parenthesis are the number of animals per group.  SPGNx=bilateral surgical removal of superior cervical ganglia, 
resulting in loss of cephalic SPGN innervation; Naive=not exposed to stress paradigm; Day 1-1hr= immediately 
after the first day of stress; Day 4-1hr-immediately after the last day of stress; Day 5-24hrs=a 24hr delay after the 
last day of stress.  (B) Representative whole mounts of toluidine blue stained dura from a naïve male (left) and 
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“Day4-1hr” stressed male (right).  Note the absence of degranulated mast cells in the naïve dura and robust signs of 





Appendix C Figure 2.  No change in density of dural mast cells.   
The density of dural mast cells did not change with sex, stress, or SPGNx, suggesting that mast cell recruitment is 




Appendix C Figure 3.  Stress-induced, sex-dependent changes in dural plasma extravasation are 
SPGN dependent.   
In intact males, but not females, stress produced a significant increase in dural plasma extravasation, which 
recovered by 24hrs after 4 days of repeated sound stress.  Effects were SPGN dependent.  Sound stress and groups 




Appendix C Figure 4.  Stress-induced increases in plasma extravasation in the ear is SPGN 
dependent.   
In intact animals, sound stress produced a significant increase in PE in the ear, a non-migraine associated tissue, 
which in males recovered by 24 hrs.  These effects were SPGN dependent.  Sound stress and groups were the same 
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